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1. Summary 
The Wnt signaling pathway controls diverse cellular processes and is implicated in stem 
cell biology, embryonic patterning, tissue homeostasis and human diseases, notably 
cancer. The regulation of the pathway is complex, and some aspects remain 
incompletely understood. This includes the signaling mechanism of R-spondins, which 
potentiate Wnt signaling, and the regulation of the endocytosis of the Wnt receptors. In 
order to obtain a better understanding for these processes, novel Wnt pathway 
components regulating Wnt signaling at the receptor level were identified and 
characterized in this thesis. 
In search for an R-spondin receptor, the leucine-rich repeat (LRR)-containing G protein-
coupled receptor 5 (LGR5) was identified. This thesis provides evidence that the orphan 
receptor LGR5, and its homolog LGR4, act as R-spondin receptors. Functionally, LGR4 
and LGR5 are required for Rspondin 3-mediated Wnt/PCP signaling during Xenopus 
development.  
Moreover, in collaboration with Prof. M. Boutros, the Rab GTPase RAB8B was 
characterized as a novel Wnt/β-catenin signaling regulator that controls LRP6 activity 
and endocytosis. This requirement of RAB8B for Wnt/β-catenin signaling was confirmed 
in Xenopus. 
Furthermore, angiopoietin-like 4 (ANGPTL4) was identified as a novel inhibitor of the 
Wnt/β-catenin signaling pathway. ANGPTL4 inhibits canonical Wnt signaling in 
mammalian cells and in Xenopus embryos, and is required for notochord formation 
during Xenopus development. In addition, ANGPTL4 is a mediator of TGFβ signaling and 
is required for mesoderm formation in Xenopus by regulating Activin/Nodal signaling. 
Similar to R-spondin 3, ANGPTL4 can bind to the syndecan family of transmembrane 
proteoglycans, which induce its clathrin-mediated endocytosis. The removal of ANGPTL4 
increases membrane levels of LRP6, resulting in higher Wnt activity, whereas ANGPTL4 
gain-of-function decreases LRP6 cell surface levels. The N-terminal domain of ANGPTL4 
is sufficient to mediate this effect. These results suggest that ANGPTL4 inhibits Wnt/β-
catenin signaling by removal of LRP6 from the plasma membrane, presumably via 
clathrin-mediated endocytosis. 
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2. Zusammenfassung 
Der Wnt Signalweg reguliert zahlreiche zelluläre Prozesse während der 
Embryonalentwicklung und der Gewebshomöostase. Fehlerhafte Wnt Signalübertragung 
ist die Ursache verschiedener menschlicher Krankheiten, insbesondere Krebs. Die 
Regulation dieses Signalweges ist sehr komplex, und einige Aspekte sind noch immer 
weitgehend unbekannt. Um die Übertragung von Wnt Signalen zwischen Zellen besser 
zu verstehen, wurden in dieser Arbeit neue Moleküle charakterisiert, die den Wnt 
Signalweg auf Rezeptorebene regulieren.   
Bei der Suche nach einem R-spondin Rezeptor wurde LGR5 als Kandidat identifiziert. Ich 
zeige hier, dass LGR5 und dessen Homolog LGR4 als Rezeptoren für R-spondin dienen. 
Die biologische Relevanz dieser Entdeckung wurde im Tiermodell belegt, wo LGR4 und 
LGR5 für die Aktivierung des Wnt/PCP Signalweges durch R-spondin 3 während der 
Xenopus Entwicklung benötigt werden.   
Ausserdem wurde in Kollaboration mit Prof. M. Boutros ein weiterer neuer Regulator 
der Wnt Signalkaskade charakterisiert. Wir konnten zeigen, dass die GTPase RAB8B die 
Aktivität und Endozytose des Wnt Rezeptors LRP6 kontrolliert. Ähnlich wie LGR4/5 wird 
auch RAB8B für die Aktivierung des Wnt/β-catenin Signalweges während der frühen 
Entwicklung von Xenopus benötigt.  
Schließlich identifiziere ich in dieser Arbeit ANGPTL4 als neuen Inhibitor des Wnt/β-
catenin Signalweges. ANGPTL4 inhibiert den Signalweg in Säugetierzellen und in 
Xenopus, und wird für die Notochord-Entwicklung in Xenopus benötigt. Wie ich hier 
darlege, reguliert ANGPTL4 zusätzlich den TGFβ Signalweg und ist an der Mesoderm-
Entwicklung in Xenopus beteiligt. ANGPTL4 wird nach Bindung an Syndecan-Proteine 
Clathrin-abhängig endozytiert. In Abwesenheit von ANGPTL4 wird LRP6 an der 
Zellmembran stabilisiert, wohingegen Expression von ANGPTL4 dazu führt, dass LRP6 
von der Membran enfernt wird. Dieser Effekt wird durch den N-Terminus von ANGPTL4 
vermittelt. Die Ergebnisse deuten darauf hin, dass ANGPTL4 den Wnt/β-catenin 
Signalweg durch Entfernung von LRP6 von der Plasmamembran inhibiert. Dies könnte 
durch Clathrin-abhängige Endzytose von LRP6 erfolgen.               
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3. Introduction 
3.1 Wnt signaling transduction cascades 
The first Wnt gene, Wnt1, was initially discovered in 1982 as a proto-oncogene activated 
by mouse mammary tumor virus (MMTV) integration.1 Since then, several other Wnt 
proteins have been identified, which now comprise a family of 19 secreted, hydrophobic 
glycoproteins in humans and mice. Wnt molecules are characterized by a signal peptide 
that mediates protein secretion, followed by a stretch of highly conserved cysteine-rich 
domains.2  
Wnts are evolutionarily conserved, and control various developmental and physiological 
processes.3 Each Wnt ligand binds a specific combination of receptor and co-receptor, 
and thereby stimulates different downstream signaling events. Based on the 
downstream signaling output, these pathways are commonly referred to as “canonical” 
and “noncanonical” Wnt signaling, and individual Wnt ligands are broadly classified by 
their ability to activate one of these cascades. For example, canonical Wnt proteins such 
as WNT1, WNT3a and WNT8 are able to induce transformation of mouse mammary 
epithelial cells and formation of secondary axis in Xenopus embryos, which are 
prototypical biological readouts for this pathway.4,5 However, this initial classification of 
Wnt signaling has since been extended, following the identification of several sub-
branches of both signaling pathways (reviewed in Niehrs, 20126). The induction of either 
of these signaling pathways depends on the cellular context and the combination of 
available receptors, rather than on the intrinsic property of the Wnt proteins.7 In the 
following chapters, Wnt/β-catenin and Wnt/PCP signaling will be addressed in detail.             
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3.1.1 Wnt/β-catenin signaling 
The Wnt/β-catenin signaling pathway controls major developmental processes such as 
axis formation and nervous system patterning, and is implicated in stem cell biology and 
human diseases, notably cancer.3,8,9  
The key event in Wnt/β-catenin signaling is the cytoplasmic stabilization of the 
transcriptional co-factor β-catenin and its subsequent nuclear translocation. In the 
absence of Wnt ligands, cytoplasmic β-catenin levels are kept low, through continuous 
proteasome-mediated degradation, which is controlled by a multiprotein complex 
containing glycogen synthase kinase 3 (GSK3), casein kinase 1 alpha (CK1α), Axin, and 
adenomatous polyposis coli (APC). The scaffold proteins Axin and APC assemble the 
destruction complex,10-13 whereas CK1α and GSK3 phosphorylate β-catenin at conserved 
Ser/Thr-residues near the amino terminus.14,15 Phosphorylated β-catenin is then 
recognized by the beta-transducin repeat containing E3 ubiquitin protein ligase (β-TrCP), 
which ubiquitinates β-catenin and thereby targets it for proteasomal degradation (Figure 
1).16-20     
Following Wnt binding to its receptors Frizzled (FZD) and low-density lipoprotein 
receptor-related protein 5/6 (LRP5/6), the ternary complex undergoes clustering on 
dishevelled (DVL) platforms.21 This in turn induces internalization of the ligand-receptor 
complex via endocytic vesicles, termed LRP6 signalosomes.21 These vesicular structures 
are acidified by the vacuolar ATPase (v-ATPase), which interacts with LRP6 via the 
prorenin receptor (PRR).22 This promotes phosphorylation of LRP5/6 by CK1γ21,23 and 
GSK324-26 and leads to membrane recruitment of the negative regulator Axin together 
with the other components of the destruction complex.27,28 Subsequently, GSK3 is 
inhibited, which stabilizes β-catenin.25 Following its stabilization, β-catenin binds to the 
lymphoid enhancer factor/T-cell factor (LEF/TCF) transcription factors, replacing the 
transcriptional co-repressor groucho, to activate Wnt target gene transcription (Figure 
1).29  
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Figure 1| Model of Wnt/β-catenin signaling. In the absence of Wnt, β-catenin is bound to the destruction 
complex, consisting of Axin, APC, CK1α and GSK3. The latter two phosphorylate β-catenin, which triggers 
its proteasomal degradation. In the presence of Wnt, the destruction complex is recruited to the Wnt-
Frizzled-LRP5/6 receptor complex and inactivated. This allows the accumulation of β-catenin and the 
activation of Wnt target gene transcription. Figure modified from Schuijers & Clevers, 2012.
30
 
   
Although GSK3 activity is critical for β-catenin stability and thus Wnt signaling, the 
molecular mechanism of GSK3 inhibition remains under debate.31 As a first and likely 
intermediate response, the phosphorylated, intracellular domain of LRP5/6 not only 
recruits, but also directly inhibits GSK3.32 Afterwards, sustained inhibition of GSK3 is 
achieved by its sequestration in multivesicular bodies (MVBs).33,34 Following 
internalization, LRP6 signalosomes are recruited to the endosomal sorting complex 
required for transport (ESCRT), which mediates sorting of these vesicles to late 
endosomes, which undergo intraluminal budding. Thereby GSK3 is sequestered in the 
lumen of MVBs and can no longer target its substrates, including β-catenin, for 
proteasomal degradation.33 In addition, it has been observed that Axin is 
dephosphorylated in response to Wnt signaling. This decreases the affinity of Axin for β-
catenin, and releases β-catenin from the destruction complex.35,36  
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3.1.2 Wnt/PCP signaling 
The Wnt/planar cell polarity (PCP) pathway does not involve the activation of β-
catenin/TCF-dependent transcription and is thereby distinct from canonical Wnt 
signaling. Wnt/PCP signaling regulates various aspects of cell migration and polarity 
during morphogenetic processes.2,37,38 In vertebrates it mediates cell movements during 
gastrulation, neural tube closure, hair cell orientation and ciliogenesis.2,39,40  
The PCP pathway was originally identified in Drosophila, where it regulates the polarity 
of actin-rich protrusions (trichomes) in the adult wing and abdomen.41 Similar to Wnt/β-
catenin signaling, FZD and DVL are also required for Wnt/PCP signaling. Genetic studies 
in Drosophila uncovered additional core components of the Wnt/PCP pathway. These 
include the four transmembrane protein Strabismus (Stbm/Vangl2), the atypical 
cadherin Flamingo (Fmi), and the cytoplasmic proteins Prickle (Pk) and Diego (Dgo). The 
atypical, cadherin-domain containing seven transmembrane protein Fmi42 differentially 
recruits FZD and Stbm to opposite sides of the cell.43 Thereby complexes of the 
transmembrane proteins Fmi and Stbm, together with the cytoplasmic protein Pk 
accumulate at the proximal side of the cell, whereas Fmi and FZD, together with DVL and 
Dgo, localize to the distal border. This separation allows the interaction of the two 
complexes at opposite sides of the cell.43,44  
In contrast to Drosophila, the molecular basis of the interaction of Fmi with the Wnt/PCP 
pathway in vertebrates remains elusive.45,46 Furthermore initial studies in Drosophila 
suggested that Wnt proteins are not required for signal transduction.43 At least in 
vertebrates, however, WNT5A and WNT11 induce the Wnt/PCP signaling pathway 
through binding to FZD receptors.47,48 This in turn recruits DVL to the plasma membrane 
and activates a downstream signaling cascade that involves the small GTPases RAC1 and 
RHOA, the Jun-N-terminal kinase (JNK), and Rho-associated coiled-coil containing 
protein kinase (ROCK). These kinases can phosphorylate and thereby activate 
transcription factors such as activating transcription factor 2 (ATF2), which induce 
transcription of target genes, thereby mediating cytoskeleton remodeling (Figure 2).2,39  
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Figure 2| Model of Wnt/planar cell polarity (PCP) signaling. Activation of the Wnt/PCP pathway, by 
binding of Wnt ligands to Frizzled and different possible co-receptors, induces recruitment of DVL and 
activation of the small GTPases RHOA and RAC1. These in turn activate ROCK and JNK, which 
phosphorylate the transcription factor ATF2. This results in actin polymerization and microtubule 
stabilization. Thereby Wnt/PCP signaling regulates cell polarity, motility and morphogenetic movements. 
Figure modified from Niehrs, 2012.
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In addition to the core components, several co-receptors for Wnt/PCP signaling have 
been identified. The heparan sulfate proteoglycans (HSPG) glypican and syndecan (SDC) 
have been shown to bind both the Wnt ligand and Frizzled and enhance Wnt signaling.49-
52 In the case of SDC4, direct interaction with DVL was observed.52 Another class of Wnt 
co-receptors are the single transmembrane receptor tyrosine kinases ROR1 and ROR2. In 
vertebrates ROR2 binds to noncanonical Wnts, like WNT5A and WNT11, and associates 
with FZD receptors to mainly transduce Wnt/PCP signaling.53,54     
As indicated above, Wnt/β-catenin and Wnt/PCP signaling are involved in a multitude of 
developmental processes and share several signaling components. A characteristic of 
Wnt/β-catenin and Wnt/PCP signaling is that they antagonize each other. The inhibition 
of one pathway will up-regulate the other branch.6    
3. Introduction 
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3.2 Wnt/β-catenin signaling regulation at the receptor level 
Wnt signaling has to be tightly regulated to prevent excessive activation, which could 
induce misregulation of cell differentiation, proliferation or migration.3 Aberrant 
regulation of Wnt signaling is associated with a variety of diseases, including bone and 
metabolic diseases, and cancer.8,55 The majority of colorectal cancer patients carry 
mutations in adenomatous APC, and to a lesser extent in Axin or β-catenin, all resulting 
in activation of the Wnt/β-catenin signaling pathway (reviewed in Clevers & Nusse, 
201255). Therefore the Wnt signaling pathway is regulated at different levels by a wide 
range of effectors.3,6,56 As regulation of Wnt signaling at the receptor level is the subject 
of this thesis, control of Wnt receptors, extracellular modifiers and different endocytic-
routes are introduced below.  
 3.2.1 Wnt receptors 
Wnt/β-catenin signaling requires activation of the co-receptor LRP5/6, which forms a 
ternary complex with Wnt ligands and the FZD receptor. These receptors can be 
regulated at different levels, either extra- or intracellularly. Furthermore, the association 
of Frizzled and LRP5/6 with different co-receptors such as the syndecans can further 
regulate downstream signaling.   
Frizzled 
The core Wnt receptors of the Frizzled family comprise 10 members in humans.57 They 
can associate with several different co-receptors and mediate not only Wnt/β-catenin, 
but also Wnt/PCP signaling. Frizzled proteins belong to the superfamily of G protein-
coupled receptors (GPCRs) and contain seven membrane-spanning domains.58,59 Frizzled 
proteins interact with Wnts via their highly conserved, large extracellular cysteine-rich 
domain (CRD).59-61 Besides Wnts, Frizzled proteins bind other secreted proteins that 
regulate its function. For instance, FZD4 has been shown to interact with Norrin, which 
binds to the CRD and mediates oligomerization of FZD4, thereby activating Wnt/β-
catenin signaling.62,63 The binding of cytoplasmic proteins to the intracellular domain of 
FZD can further regulate the receptor. One of the best-characterized FZD interacting 
proteins is the scaffold protein DVL.64 DVL is involved in Wnt/β-catenin, as well as 
Wnt/PCP signaling and mediates interaction of the receptor with several other 
3. Introduction 
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cytoplasmic proteins.2 In the case of Wnt/β-catenin signaling, DVL contributes to the 
recruitment of the destruction complex, whereas in Wnt/PCP signaling it binds to 
atypical PKC (aPKC) or DVL-associated activator of morphogenesis 1 (DAAM1), which 
mediate the activation of the small GTPases RHO and RAC.65  
LRP5 and LRP6 
LRP5, LRP6 and their Drosophila homolog Arrow are type-I single-pass transmembrane 
proteins and constitute a subfamily of the low density lipoprotein (LDL) receptor family. 
They are characterized by a large extracellular domain and a short cytoplasmic tail, 
containing five Pro-Pro-Pro-Ser/Thr-Pro (PPPSP) sites and several Ser/Thr clusters.26,66 
The extracellular domain (ECD) contains different Wnt binding sites and mediates the 
interaction with Wnt and Frizzled, resulting in the formation of a ternary signaling 
complex.67 The regulation of LRP5/6 activity is mainly achieved by phosphorylation of 
the cytoplasmic domain of the protein. The PPPSP sites are required for Wnt/β-catenin 
signaling, as evidenced by the fact that an LRP6 mutant lacking those domains is inactive 
in signaling.28,68 The phosphorylation of these PPPSP sites is mediated by proline-
directed kinases, such as GSK3, upon activation of Wnt signaling (Figure 3).24 Thereby, 
GSK3 acts as a dual regulator of Wnt signaling, as it inhibits Wnt signaling by 
phosphorylation of β-catenin and activates it by phosphorylation of LRP6.24 
Phosphorylation of the PPPSP sites primes LRP6 for phosphorylation by CK1γ at 
neighboring Ser residues (Figure 3). The phosphorylation of all sites promotes Axin 
recruitment to the plasma membrane and thereby activates Wnt signaling.23  
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Figure 3| LRP6 phosphorylation by GSK3 and CK1γ. The intracellular domain of LRP6 has five PPPSP and 
CK1 phosphorylation sites. Phosphorylation of PPPSP sites by GSK3 primes LRP6 for CK1γ phosphorylation 
upon extracellular Wnt stimulation. Figure modified from Davidson et al., 2009.
69
 
 
The activity of LRP6 is also regulated by other kinases. For example, serine/threonine 
kinase CK2 is activated upon Wnt stimulation and phosphorylates LRP6 at a highly 
conserved Ser1579 site. This phosphorylation promotes binding of the endocytic 
adaptor disabled-2 (DAB2), which inhibits Wnt signaling by inducing clathrin-dependent 
LRP6 endocytosis.70 
Syndecans 
Syndecans are a family of four transmembrane proteoglycans, which were described as 
co-receptors of Wnt signaling. Based on sequence homology, the vertebrate syndecans 
can be divided into two subclasses, with SDC1 and SDC3 constituting one class, and SDC2 
and SDC4 making up the other.71,72 Syndecans contain an extracellular domain with 
attachment sites for three to five heparan sulfate (HS) or chondroitin sulfate (CS) 
glycosaminoglycan (GAG) chains, a single-pass transmembrane domain, and a short 
cytoplasmic domain (Figure 4).72 The HS chains mediate interaction with a variety of 
growth factors such as Hedgehog, FGFs, TGFβ, and Wnts.73 Furthermore, interaction 
with several extracellular matrix proteins has been described. This mostly requires 
modification of the GAG chains by sulfatases, generating highly specific binding sites.74 
Whereas the homology of the ECD is fairly low, the transmembrane domain is highly 
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conserved between the four syndecans. The cytoplasmic domain can be divided into 
three regions, containing two highly conserved (C1, C2) and a variable (V) domain 
(Figure 4). These domains contain binding sites for several cytoplasmic proteins 
(reviewed in Tkachenko, 200575), coupling syndecans to different downstream 
processes.  
The four syndecan members show distinct expression patterns, which are tightly 
regulated during development. SDC1 is expressed very early in development in epithelial 
and mesenchymal tissue, whereas SDC3 is mainly expressed in neural and 
musculoskeletal tissue. SDC2 is detected in cells of mesenchymal origin, as well as in 
neuronal and epithelial cells. SDC4, on the other hand, is ubiquitously expressed from 
early stages of development.75,76   
 
 
 
Figure 4| Structure of syndecans. The extracellular domain of all four syndecans with attachment sites for 
3-5 heparan sulfate (HS) or chondroitin sulfate (CS) chains is shown in light grey. The transmembrane 
domain links the extracellular domain to the intracellular cytoplasmic part of the protein, consisting of one 
variable and two conserved (C1, C2) regions. The four syndecans (SDC) differ in their extracellular domain 
and variable region. Figure modified from Pap & Bertrand, 2013.
77
 
 
Of all syndecans, the function of SDC4 is best described. SDC4 regulates Wnt/PCP 
signaling in Xenopus via direct interaction with FZD and DVL and recruitment of DVL to 
the plasma membrane.52 Moreover, SDC4 was shown to bind RSPO3, which also 
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activates Wnt/PCP signaling.78 In this manner syndecans add another level of regulation 
to the Wnt receptor complex. 
3.2.2 Extracellular modifiers 
Besides Wnt ligands, several other proteins have been identified that can interact with 
the Wnt (co-)receptors and thereby regulate Wnt signaling. The most prominent ones 
are R-spondins.  
R-spondins 
R-spondins (roof plate specific spondin, RSPO) comprise a family of four secreted 
proteins, which potently enhance Wnt/β-catenin and Wnt/PCP signaling in a Wnt-
dependent manner.78-80 The four R-spondin proteins consist of an N-terminal signal 
peptide, two furin domains which are required for Wnt/β-catenin signaling,79 and one 
thrombospondin type I domain (TSP), which promotes Wnt/PCP signaling (Figure 5).78 
Interestingly, R-spondins enhance Wnt signaling even in the presence of low amounts of 
Wnt ligands. In the absence of Wnts, R-spondins are not able to induce β-catenin 
accumulation.81,82 
 
 
 
Figure 5| Domain organization of R-spondins. The R-spondin family members consist of an N-terminal 
signal peptide (SP), mediating secretion, two cysteine-rich furin-like domains (Furin1, Furin2), a single 
thrombospondin type 1 repeat (TSP) and a positively charged C-terminal tail of variable length. The Furin 
domains are implicated in Wnt/β-catenin signaling and the TSP domain is required for Wnt/PCP signaling. 
Figure modified from Jin & Yoon, 2012.
83
  
 
R-spondins have been shown to control embryonic development and 
differentiation,79,84-86 and can stimulate the proliferation of crypt stem cells in the 
intestine via activation of Wnt/β-catenin signaling.87,88 However, the molecular 
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mechanism of R-spondin activity in Wnt signaling remained elusive. Several receptors 
were proposed as binding partners of R-spondins, including LRP6 and Kremen, which 
however could not be confirmed.78,81 Recently, syndecans were identified as receptors 
for RSPO2 and RSPO3, binding to their TSP domain.78 In Xenopus, SDC4 and RSPO3 are 
essential for convergent extension movements during gastrulation and head cartilage 
morphogenesis.78 Syndecans are known to undergo internalization upon ligand binding. 
Consistently, RSPO3 binding induces SDC4-dependent, clathrin-mediated endocytosis of 
the FZD-WNT5A complex, which is essential for Wnt/PCP signaling.78    
3.2.3 Regulation of Wnt signaling by endocytosis 
There is increasing evidence that internalization of the Wnt-receptor complex can not 
only attenuate signal transduction, but is also required for pathway activation.89 In this 
context, two major signaling events have been described, namely clathrin and caveolin-
mediated endocytosis.    
Clathrin-mediated endocytosis 
In clathrin-mediated endocytosis, ligand-receptor complexes accumulate in “coated pits” 
at the plasma membrane (Figure 6). Clathrin-coated pits consist of cytosolic coat 
proteins, which assemble into a cage-like structure. This requires clathrin, the major 
assembly unit, which is comprised of three heavy and three light chains forming a three-
legged structure, also known as triskelion.90 Besides clathrin, several other proteins such 
as the assembly protein 2 (AP-2), are involved in the formation of the polygonal clathrin 
coat (Figure 6).91 Other proteins like β-arrestin1/2 work as adaptor proteins, which on 
the one hand bind AP-2 and clathrin, and on the other hand interact with various 
activated GPCRs.92 Thereby β-arrestins mediate the accumulation of these receptors in 
clathrin-coated pits.93 During the late process of clathrin-coated vesicle (CCV) formation, 
dynamin, a GTP-binding protein, assembles at the neck of invaginating pits and mediates 
membrane fission.94 After internalization, CCVs are uncoated and fuse with early 
endosomes. At this step membrane proteins can either be recycled to the plasma 
membrane, or transported to late endosomes and lysosomes for degradation. (reviewed 
in Kikuchi et al., 200795)   
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Figure 6| Model of clathrin-mediated endocytosis. Ligand-receptor complexes are concentrated in 
clathrin-coated pits in the plasma membrane. These structures are assembled by cytosolic coat proteins, 
including clathrin and assembly protein 2 (AP-2). Clathrin-coated vesicles undergo endocytosis and are 
uncoated after internalization, and fuse with early endosomes. Figure modified from Dobrowolski & De 
Robertis, 2012.
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In the case of Wnt/PCP signaling, only clathrin-mediated endocytosis seems to be 
essential for the induction of the signaling pathway. Wnt/PCP signaling is mainly induced 
by binding of Wnt ligands to their Frizzled receptors. As Frizzled receptors themselves 
are GPCRs,58,59 β-arrestin is implicated in the internalization of FZD. Upon binding of 
FZD4 to WNT5A, FZD4 undergoes internalization, mediated by β-arrestin2. This requires 
DVL2, which recruits β-arrestin2 to the plasma membrane and thereby induces the 
internalization of FZD4.97 Besides its interaction with β-arrestin, DVL2 also binds a 
subunit of AP-2. This association mediates the Wnt-dependent internalization of FZD4 
and is essential for Wnt/PCP signaling in Xenopus.98 In addition to Wnts, RSPO3 also 
induces clathrin-mediated endocytosis of Frizzled, which is essential for Wnt/PCP 
signaling.78  
For Wnt/β-catenin signaling there are several reports showing the importance of 
caveolin-mediated endocytosis for activation of downstream signaling (see below). 
However, it has been proposed that clathrin-dependent internalization is also involved 
in the activation of β-catenin signaling. In murine L-cells, β-catenin accumulation 
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induced by WNT3A was suppressed upon addition of clathrin specific inhibitors.89 
Furthermore, inhibition of β-arrestin in mouse embryonic fibroblasts or Xenopus blocked 
β-catenin accumulation after Wnt stimulation.99 In addition to activation of Wnt/β-
catenin signaling, the internalization via clathrin-dependent routes can also inhibit the 
pathway. This is achieved by binding of DKK1 to LRP5/6 and Kremen. The ternary 
complex is rapidly internalized in a clathrin-dependent manner and attenuates Wnt 
signaling by removal of LRP5/6 from the plasma membrane.100  
Caveolin-mediated endocytosis 
Caveolin-mediated endocytosis takes place in regions of the plasma membrane called 
caveolae. These are flask-shaped plasma membrane invaginations rich in cholesterol and 
sphingolipid, which concentrate many membrane transporter and signaling 
molecules.101,102 Caveolae are formed by caveolin, which directly binds cholesterol and 
confers the characteristic shape and structural organization. Caveolin is an integral 
membrane protein and self-associates to form a striated caveolin coat on the surface of 
membrane invaginations (Figure 7).103,104 Membrane fission of caveolae also involves 
dynamin, similar to clathrin-mediated endocytosis.94 In contrast to CCVs, caveolin is 
stably associated with the plasma membrane of the internalized vesicles and caveolae 
are only slowly internalized102 (reviewed in Lajoie & Nabi, 2010105).  
Wnt/β-catenin signaling proceeds via caveolin-mediated endocytosis to trigger 
downstream signaling. In response to Wnt signaling, LRP6 has been found in intracellular 
aggregates that contain caveolin.21 Consistently, it has been shown that LRP6 undergoes 
caveolin-mediated endocytosis upon Wnt stimulation, and inhibition of caveolin-
dependent endocytosis blocks WNT3A-induced β-catenin accumulation.106,107     
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Figure 7| Model of caveolin-mediated endocytosis. Upon binding of Wnt to Frizzled and LRP6, DVL is 
recruited to the plasma membrane. DVL is required for the polymerization of the receptors in caveolae 
and endocytosis via caveolin-coated vesicles. Other components of the Wnt/β-catenin signaling pathway 
are not shown for simplicity. Figure modified from Dobrowolski & De Robertis, 2012.
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3.3 Wnt signaling during Xenopus development 
Xenopus is an important and established model system for studying Wnt signaling in 
vertebrates. Major advantages are the large size of the embryos and easy accessibility, 
which allows microinjection experiments, short generation times and the high degree of 
conservation of essential cellular and molecular mechanisms, including the Wnt 
signaling pathway.108,109    
During Xenopus development, Wnt/β-catenin signaling is first involved in the 
establishment of the dorsal-ventral (D-V) axis and later in the patterning of the anterior-
posterior (A-P) axis. These two processes can be divided into two separate events: 
Maternal Wnt signaling, which is controlled by molecules inherited from the mother, 
and zygotic Wnt signaling, which begins after the initiation of transcription in the 
embryo.110 D-V axis determination starts with fertilization of the egg. Sperm entry 
initiates rotation of the cortical cytoplasm, which relocates dorsal determinants from the 
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vegetal pole to the dorsal side.111-114 These determinants include maternal WNT11 
mRNA,115 which induces the asymmetric stabilization and nuclear translocation of β-
catenin (Figure 8A).116-118 Thereby Wnt signaling induces dorsal-specific gene expression, 
which is responsible for Spemann organizer formation.116,119 This signaling center 
dorsalizes the three germ layers and is required for the formation of the A-P axis.  
Zygotic Wnt/β-catenin signaling mediates A-P axis specification by establishing a linear 
signaling gradient.120 Wnt/β-catenin signaling activity is high at the posterior pole, where 
Wnt signaling promotes posterior cell fates.121,122 In the anterior part of the embryo, 
Wnt activity is low, due to secretion of Wnt antagonists (Figure 8B).123-125 Accordingly, 
zygotic Wnt/β-catenin gain-of-function induces posteriorization, characterized by lack of 
head structures, whereas conversely, loss-of-function causes anteriorization, marked by 
big heads, enlarged cement glands and short trunks.  
 
 
Figure 8| Xenopus axis specification by maternal and zygotic Wnt/β-catenin signaling. (A) Maternal 
Wnt/β-catenin signaling establishes the dorsal (D) – ventral (V) axis. After fertilization, cortical rotation 
(black dotted line) induces accumulation of β-catenin at the future dorsal site, where it activates gene 
transcription leading to formation of the Spemann organizer. (B) Zygotic Wnt/β-catenin signaling is 
involved in anteroposterior axis specification. Secretion of Wnt antagonists in the anterior (A) region and 
expression of Wnt ligands in the posterior (P) region establish a Wnt gradient along the embryonic axis, 
which is essential for axis formation. Figure modified from Hikasa & Sokol, 2013.
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Wnt/PCP signaling also contributes to Xenopus development, by regulating cell 
movements during gastrulation. This includes convergent extension (CE) movements, 
which drive the elongation of the body axis. In this process, dorsal mesodermal cells 
align with mediolateral orientation. These cells possess protrusive activities on their 
lateral surfaces, which allow directed cell movements. Thereby cells intercalate and the 
tissue narrows (convergence) mediolaterally. At the same time, the tissue elongates 
along the A-P axis (extension), which results in the formation of the A-P body axis (Figure 
9).126,127 This process is tissue-autonomous, because explants of the dorsal marginal 
zone (Keller explants) undergo elongation in the absence of neighboring, mesodermal 
tissue.128 Because Wnt/PCP signaling is essential for convergent extension, interfering 
with the pathway results in shortened embryonic body axis and defects in neural tube 
closure (spina bifida).78,129,130 
 
 
 
Figure 9| Convergent extension movements during Xenopus gastrulation. Schematic illustration of the 
dorsal vegetal region of a Xenopus gastrula embryo. Arrows indicate movements of cells. Mesodermal 
cells align mediolaterally (L↔M↔L) and based on their protrusive activity at the mediolateral edges, 
these cells intercalate. Thereby sheets of cells narrow mediolaterally (convergence) and at the same time 
elongate in anterior (A) posterior (P) direction (extension), which establishes formation of the A-P body 
axis. Figure modified from Tada & Kai, 2009.
40
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4. Aim of the thesis 
The Wnt signaling pathway has been studied extensively, however several aspects of the 
transduction cascade, especially at the level of the receptors, remain unresolved. The 
aim of this thesis is to identify new regulators of the Wnt signaling pathway, which 
control Wnt signaling at the receptor level. These regulators should be analyzed 
regarding their molecular mechanism and their physiological relevance in Wnt signaling 
and validated in vivo, using Xenopus as a model organism. This should lead to a better 
understanding of the Wnt signaling pathway. Here I describe three new Wnt regulators 
that affect Wnt signaling at the receptor level: 
Chapter 1: LGR4 and LGR5 are R-spondin receptors mediating Wnt signaling. R-
spondins enhance both Wnt/β-catenin and Wnt/PCP signaling in the presence of Wnt.78-
80 The molecular mechanism of Wnt signal enhancement and the reason for the 
requirement of Wnts to enhance both signaling pathways are incompletely understood. 
We thus aimed to identify novel R-spondin receptors. The requirement of these 
receptors for R-spondin mediated Wnt/PCP signaling was analyzed in Xenopus embryos.  
Chapter 2: RAB8B is required for Wnt/β-catenin signaling in Xenopus. Endocytosis plays 
an important role in signal transduction of the Wnt pathway,89 but how endocytosis of 
the Wnt receptors is regulated is incompletely understood. The small GTPase RAB8B was 
identified as regulator of LRP6 receptor endocytosis in an RNAi screen. To analyze if the 
function of RAB8B on Wnt/β-catenin signaling is conserved, the effect of RAB8B loss-of-
function was analyzed in Xenopus.  
Chapter 3: ANGPTL4 binds syndecans and inhibits Wnt/β-catenin signaling by 
promoting LRP6 internalization. ANGPTL4 was identified in a genome-wide siRNA 
screen with the aim to discover novel molecules that regulate Wnt signaling at the 
receptor level. The function and mechanism of ANGPTL4 in Wnt signaling was 
investigated in vitro and the biological function was characterized during the early 
development of Xenopus embryos.  
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5. Chapter 1: LGR4 and LGR5 are R-spondin receptors mediating 
noncanonical Wnt signaling in Xenopus 
5.1 Introduction 
5.1.1 Leucine-rich repeat-containing G protein-coupled receptor family 
The G protein-coupled receptor (GPCR) family represents one of the largest families of 
transmembrane proteins comprising more than 800 receptors.131 The main 
characteristic of GPCRs is the presence of seven transmembrane domains. Through their 
membrane-spanning domain, these receptors convert extracellular signals into 
intracellular signaling responses by activation of heterotrimeric G proteins. These 
extracellular stimuli can be quite diverse, comprising sensory and chemical signals, 
including light, odor, pheromones, hormones and neurotransmitters.132 The binding of 
the respective ligand to GPCRs induces the activation of heterotrimeric G proteins, 
which positively or negatively regulate the activity of effector molecules, such as 
enzymes and ion channels. This causes a change in ion composition, or second 
messenger levels, which in turn induces cellular responses.133,134 Desensitization of GPCR 
signaling is achieved by uncoupling of GPCRs from heterotrimeric G proteins in response 
to phosphorylation by G protein-coupled receptor kinases (GRKs). The phosphorylation 
of GPCRs promotes binding of β-arrestin, which mediates the uncoupling process. 
Furthermore, β-arrestin binds to AP-2 and clathrin and thereby facilitates internalization 
of GPCRs via clathrin-mediated endocytosis. This internalization attenuates downstream 
signaling.92,93 Based on phylogenetic analysis, the human GPCRs can be divided into five 
subgroups: Glutamate, Rhodopsin, Adhesion, Frizzled/Taste2 and Secretin.131,135  
The leucine-rich repeat-containing G protein-coupled receptors (LGRs) belong to the 
Rhodopsin family and can be divided into three subgroups, based on their unique 
domain arrangement (Figure 10A,B).136 The Type A subgroup is constituted by the 
hormone receptors for follicle-stimulating hormone (FSHR/LGR1), luteinizing hormone 
(LHR/LGR2) and thyroid-stimulating hormone (TSHR/LGR3). LGR7 and LGR8 bind to 
peptides of the relaxin family and are classified as type C.137-139 The type B receptors 
LGR4-6 share 50% sequence identity at the amino acid level.136 The structure of the LGRs 
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is characterized by a large N-terminal extracellular domain containing a series of 9 to 17 
leucine-rich repeats (LRR), which in the case of subgroup A and C are crucial for ligand 
binding (Figure 10B). In the case of LGR4, LGR5, and LGR6, the 17 LRRs are flanked by N- 
and C-terminal cysteine-rich domains (Figure 10C) (reviewed in Tang et al., 2012135). 
LGRs are of ancient evolutionary origin.140 Apart from vertebrates and insects, LGR 
homologues were found in sea anemone, mollusk, and the nematode C.elegans.141-145  
 
 
Figure 10| LGR subfamilies and domain organization. (A) Phylogenetic relationship between LGR 
subfamilies. Group A includes follicle-stimulating (FSHR/LGR1), luteinizing (LHR/LGR2) and thyroid-
stimulating (TSHR/LGR3) hormone receptors. Group B contains LGR4, LGR5 and LGR6. Group C comprises 
LGR7 and LGR8, receptors of the relaxin family. (B) Domain structure of the three groups. Group A 
contains 9 leucine-rich repeats (LRR), whereas group B contains 17 LRRs and group C 10 LRRs. Hinge, Hinge 
domain; 7 TM, seven transmembrane domain; LDL, low density lipoprotein. (C) Predicted structure of 
LGR5, consisting of a large extracellular domain of 17 LRRs, which are linked to the cytoplasmic domain via 
seven transmembrane helices. Panel A and B modified from Tang et al., 2012
135
, panel C was taken from 
Barker & Clevers, 2010.
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The expression pattern and functions of LGR4, LGR5 and LGR6 are quite distinct.135,146 
LGR5 is a marker of gastrointestinal, colon, stomach and hair follicle stem cells.147,148 It 
was shown that LGR5 expression in mouse small intestine and colon is restricted to a 
very specific cell type, called crypt base columnar (CBC) cells, which are interspersed 
between Paneth cells at the crypt base. These LGR5 positive cells are long-lived and 
multipotent.147,149 Similarly, the epithelial stem cells of the gastric gland in the stomach 
and of the follicle bulge in the hair follicle of the skin all express LGR5.147,148,150 These 
cells have in common that their self-renewal and differentiation is controlled by Wnt 
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signaling.151-153 Furthermore, it was described that Wnt signaling regulates the 
expression of LGR5.154 Mutations that cause an up-regulation of LGR5 result in the 
formation of colorectal cancers and tumors of the ovary, and they promote cell 
proliferation and tumor formation in basal cell carcinoma.155,156 The knockout of LGR5 in 
mice results in neonatal lethality characterized by ankyloglossia and gastrointestinal 
distension.157   
While LGR5 expression is mainly restricted to stem cell compartments, LGR4 shows a 
wide tissue distribution, with strong expression in cartilage, kidney, stomach, heart, 
reproductive tracts, hair follicles and cells of the nervous system.158,159 Therefore, LGR4 
knockout mice display a pleiotropic phenotype, characterized by several developmental 
defects, including intrauterine growth retardation associated with embryonic and 
perinatal lethality,159 defective development of the gall bladder and cystic ducts,160 
dysfunctions in bone formation and remodeling,161 and several other organic defects 
(reviewed in Barker & Clevers, 2010146). Overexpression of LGR4 increases the 
invasiveness and metastasis of human colon carcinoma.162 Whereas LGR5 is a marker of 
several stem cells, LGR4 rather appears to be required for the maintenance of adult 
stem cells in the intestine and is involved in the development of different embryonic 
tissues, which are of mesodermal, endodermal and ectodermal origin.146,158,163 
Similar to LGR5, LGR6 has been shown to be a marker of multipotent stem cells in the 
hair follicle of the skin, which are located directly above the bulge cells in the hair 
follicle.164,165 The LGR6 positive cells give rise to all lineages of the skin and are involved 
in wound repair in adult mice, including the formation of new hair follicles.165 Similar to 
LGR4 and LGR5, LGR6 is also implicated in cancer. Total exon sequencing revealed that 
LGR6 is often mutated in colon cancer.166 Furthermore, the promoter region of LGR6 is 
hypermethylated in 20-50% of human colorectal cancer samples.167,168  
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Although LGR4, LGR5 and LGR6 are all associated with cancer and are markers of various 
stem cells, as in the case of LGR5 and LGR6, their specific function within these cells is 
incompletely understood. This can be mainly attributed to the fact that LGR ligands are 
unknown. Here we identify R-spondins as LGR ligands. R-spondins were previously 
characterized as orphan ligands that enhance Wnt/-catenin and Wnt/PCP signaling.79 
However, their mechanism of action has remained elusive. By showing direct interaction 
between LGRs and R-spondins, we provide evidence that Wnt signal amplification of R-
spondins is regulated via LGRs.  
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5.2 Results  
In search for an R-spondin receptor a genome-wide siRNA screen was performed in the 
Niehrs laboratory in HEK293T cells,22 which led to the initial identification of LGR5 as a 
positive regulator of R-spondin-mediated Wnt signaling. We have shown before that 
RSPO3 amplifies both Wnt/β-catenin and Wnt/PCP signaling in Xenopus embryos.78 
Therefore we used Xenopus as a model organism to determine whether LGR5 could 
function as R-spondin receptor in Wnt/PCP signaling. Besides LGR5, LGR4 and LGR6 were 
also described as orphan receptors and are structurally similar to LGR5. However, 
Xenopus does not have an LGR6 orthologue, and was thus not investigated here.  
5.2.1 LGR4 and LGR5 show distinct expression patterns in Xenopus tropicalis 
The expression of LGR4 and LGR5 in Xenopus has not been described so far. Expression 
analysis of LGR4 and LGR5 showed maternally stored mRNA, which decreased until 
blastula stage (stage 10). After gastrulation the zygotic transcripts increased and reached 
comparable levels at tailbud stage (stage 34) (Figure 11A). In the three germ layers of 
Xenopus embryos, LGR4 showed an ubiquitous expression, whereas LGR5 was 
predominantly expressed in the endoderm (Figure 11B).  
 
 
Figure 11| Expression analysis of LGR4 and LGR5 during Xenopus development. (A) qPCR analysis of 
LGR4 and LGR5 in Xenopus embryos using different developmental stages. ODC was used for 
normalization. (B) Expression analysis of LGR4 and LGR5 in Xenopus germ layers. Xenopus explants of 
stage 10 embryos were analyzed by qPCR for LGR4 and LGR5 expression. LGR4 shows expression in all 
three germ layers. LGR5 expression is highest in endodermal cells. Figure from Glinka et al., 2011.
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5.2.2 LGR4 Morpholino rescues RSPO3 induced spina bifida  
Wnt/PCP signaling is a key regulator of convergent extension movements during 
gastrulation. Misregulation of genes involved in this process, e.g. R-spondin 3 (RSPO3), 
results in gastrulation defects.78 To investigate if LGR4 and LGR5 also affect gastrulation 
movements, similar to RSPO3, Xenopus LGR4 and human LGR5 messenger RNAs (mRNA) 
were injected into Xenopus embryos. Overexpression of both LGR4 and LGR5 induced 
gastrulation defects in Xenopus embryos (Figure 12). This phenotype is similar to the 
gastrulation defect and spina bifida observed after RSPO3 mRNA injection,78 and 
suggests a possible function of LGR4 and LGR5 in Wnt/PCP signaling in Xenopus. 
 
 
Figure 12| Gain of function of LGR4 and LGR5 causes gastrulation defects in Xenopus. Embryos were 
injected equatorially at 4-cell stage with messenger RNA (mRNA) for PPL, Xenopus LGR4 and human LGR5, 
and phenotypes were analyzed at tailbud stage. 
 
The spina bifida phenotype induced by RSPO3 overexpression was rescued in a dose-
dependent manner by co-injection of an antisense Morpholino oligonucleotide (Mo1) 
targeting the 5’ untranslated region (UTR) of LGR4 (Figure 13A,B). Co-injection of a 
Morpholino targeting the 5’UTR of LGR5 (LGR5 Mo1), was not able to rescue the RSPO3-
induced gastrulation defect (data not shown). The results indicate a requirement of 
LGR4, but not LGR5, for RSPO3-induced spina bifida in Xenopus embryos. 
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Figure 13| RSPO3 signaling requires LGR4 to induce gastrulation defects in Xenopus embryos. (A) 
Embryos were injected equatorially at 4-cell stage with Xenopus RSPO3 mRNA (250 pg) and control or 
LGR4 Mo1 (20 ng co Mo, 10 ng (+) or 20 ng (++) LGR4 Mo1). Scale bar corresponds to 500 µm. (B) 
Statistical analysis of the injected Xenopus embryos. For each sample 20 embryos were analyzed and the 
percentage of spina bifida phenotypes was determined at stage 25. Figure from Glinka et al., 2011.
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5.2.3 LGR4 and LGR5 are required for RSPO3-mediated Wnt/PCP signaling in Xenopus 
We investigated the role of LGR4 and LGR5 in RSPO3-mediated noncanonical Wnt 
signaling by using a specific reporter for Wnt/PCP signaling in early Xenopus embryos, 
ATF2-luciferase.170 Expression of the ATF2-luciferase reporter was induced by WNT5A 
mRNA injection (Figure 14A). Stimulation of the ATF2-luciferase activity was inhibited by 
either RSPO3 Mo, as described before,78 or by six individual LGR4 and LGR5 Mos. 
Because the rescue of LGR4/5 Mos proved technically difficult, six Morpholinos, 
targeting different sites of LGR4 and LGR5, were designed to confirm Mo specificity. The 
same inhibitory effect was observed when PCP signaling was activated using a 
combination of FZD7 and RSPO3 mRNAs. The elevated ATF2 reporter activity was 
decreased to basal levels after co-injection of either LGR4 or LGR5 Mo1 (Figure 14B). 
Besides exogenous activation of the PCP signaling pathway, the effect of LGR4/5 Mo1 on 
endogenous PCP signaling was investigated. For this purpose, low doses of the RSPO3, 
LGR4 and LGR5 Mos, which by themselves had no effect on the reporter activity, were 
combined. Co-injection of RSPO3 Mo with either LGR4, or LGR5 Mo1, or both LGR Mos 
together, resulted in a decrease in ATF2-luciferase activity (Figure 14C).  
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Figure 14| LGR4 and LGR5 are required for Wnt/PCP signaling in Xenopus. (A-C) ATF2-luciferase activity is 
reduced by LGR4/5 Mos in Xenopus. Embryos were injected equatorially at 4-cell stage with ATF2-luc 
reporter (100 pg) and Renilla reporter plasmids (25 pg) and the indicated Morpholinos (40 ng LGR4 Mo1, 
10ng LGR4 Mo2/3, 10 ng LGR5 Mo1, 5 ng LGR5 Mo2, 2.5 ng LGR5 Mo3, 10 ng RSPO3 Mo (A, B), 20 ng LGR4 
Mo1, 5 ng LGR5 Mo1 (C)) and mRNAs (500 pg WNT5A, 250 pg FZD7, 250 pg RSPO3). Luciferase reporter 
assays were performed from whole embryos at stage 11. Luciferase activity of embryos injected with co 
Mo was set to 100%. RLA, relative luciferase activity. Figure from Glinka et al., 2011.
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These results provide evidence for a requirement of LGR4 and LGR5 for RSPO3-mediated 
Wnt/PCP signaling in Xenopus embryos.  
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5.3 Discussion 
The phenotypic analysis and ATF2 reporter assays indicate that the effect of RSPO3 on 
Wnt/PCP signaling in Xenopus embryos is mediated via LGR4 and LGR5.  
5.3.1 LGR4 and LGR5 are bone fide R-spondin receptors 
In early Xenopus embryos, injection of RSPO3 mRNA results in gastrulation defects, 
which are due to Wnt/PCP signaling pathway misregulation.78 The observations that 
LGR4 as well as LGR5 mRNAs gave rise to a similar phenotype, and that RSPO3 
overexpression could be rescued by LGR4 depletion, suggested that they may act in the 
same pathway as RSPO3. Similarly, it was shown by de Lau et al. that genetic deletion of 
LGR4/5 in mouse intestinal crypt cultures phenocopies RSPO1 withdrawal,171 which 
further supports a synergistic action of R-spondins and LGRs in vivo. Indeed, additional 
experiments performed in the course of this study, including cell surface and in vitro 
binding assays, confirmed that R-spondins directly interact with LGRs.169 We thus 
identify R-spondins as LGR ligands, which was independently confirmed by other 
groups.171,172  
Although we observed that both LGR4 and LGR5 bind to R-spondins in vitro, LGR5 
depletion was not sufficient to rescue the RSPO3 overexpression phenotype in Xenopus 
embryos. A possible explanation may be the different expression patterns of LGR4 and 
LGR5. Whereas LGR4 shows a ubiquitous expression in all three germ layers, LGR5 is 
predominantly expressed in endodermal tissue. During gastrulation, RSPO3 is mainly 
expressed in mesodermal cells, which undergo cell migration and convergent extension 
during gastrulation.78 Because of this distinct expression pattern, it is possible that 
RSPO3 and LGR4, but not LGR5, interact during gastrulation. It should be noted, 
however, that LGR5 may preferentially bind other R-spondin family members not 
investigated here, and thereby contributes to Xenopus development. 
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5.3.2 LGR4 and LGR5 in Wnt signaling 
R-spondins were discovered in 2004 as enhancers of WNT3A-induced Wnt signaling.79 
Carmon et al. were the first to show that this potentiating effect of R-spondins is 
dependent on LGR4 and LGR5, whereas the maximal activity of Wnt/β-catenin activation 
is determined by the level of WNT3A and the presence of the Wnt co-receptor LRP6. 
Moreover, their data indicate that this potentiation is mediated by enhancing Wnt-
induced LRP6 phosphorylation.172 LGR4 and LGR5 belong to the GPCR superfamily, which 
interact with heterotrimeric G proteins and β-arrestin.131,132 Carmon et al. analyzed 
whether LGR4 and LGR5 are coupled to heterotrimeric G proteins or β-arrestin to 
mediate their function in Wnt/β-catenin signaling. Although LGR4/5 show sequence 
homology to the Rhodopsin family of GPCRs,136 they do not bind to G proteins or β-
arrestins when stimulated by R-spondins. However, it cannot be excluded that LGRs bind 
ligands other than R-spondins, which require G proteins for signal transduction. Finally, 
these authors showed that LGR4 and LGR5 are constitutively internalized into large 
intracellular vesicles. Upon binding, R-spondins undergo co-internalization with each of 
the two receptors. The nature of this internalization was not analyzed further. We 
extended on these findings by showing that LGR4 is co-internalized with RSPO3 by 
clathrin-mediated endocytosis.169 Thereby, RSPO3-mediated Wnt/β-signaling is using a 
different endocytic route compared to WNT3A-induced signaling, which requires 
caveolin-mediated endocytosis.169  
In another study, de Lau et al. identified R-spondins as ligands for LGR4 and LGR5, by 
using both receptors as baits in a tandem affinity purification mass spectrometric 
setup.171 Using this strategy, they identified LGR5, LRP6 and FZD5/7 as interaction 
partners of LGR4, and FZD5, LRP5 and LRP6 as LGR5 interaction partners. Hence, LGR4 
and LGR5 associate with the FZD/LRP6 receptor complex. Besides binding the Wnt 
receptors, LGR4, LGR5 and also LGR6 were shown to bind all four R-spondins. In contrast 
to the members of type B family of Rhodopsin proteins, type A (LGR1, LGR3) and type C 
(LGR7, LGR8) receptors did not associate with RSPO1, showing a clear specificity of R-
spondins for LGR4/5/6. The affinity of RSPO1 for LGR5 lies in the low nanomolar range 
and is in accordance with our results for binding of RSPO3 to LGR4 and LGR5.169 Whereas 
we were able to show that the interaction of LGR4/5 and RSPO3 requires the two furin 
5. Chapter 1: LGR4 and LGR5 are R-spondin receptors mediating noncanonical Wnt signaling in Xenopus 
30 
 
domains of RSPO3,169 de Lau et al. identified the first LRR domains at the N-terminus of 
LGR5 to be essential for RSPO1 binding. This is in accordance with type A homologues of 
the Rhodopsin subfamily, where binding of the glycoprotein hormones involves the N-
terminal LRR ectodomain.173 In addition to their cell culture studies, de Lau et al. 
performed genetic deletions of LGR4 and LGR5 in mouse intestinal crypt cultures, which 
phenocopied RSPO1 withdrawal and induced the demise of the cultured crypt organoids. 
This effect was efficiently rescued by WNT3A overexpression, indicating that strong 
Wnt/β-catenin signal activation can overcome loss of LGR4/5 receptors. 
For Wnt/PCP signaling it was shown that SDC4 mediates PCP signaling and binds to the 
TSP1 domain of RSPO3.78 As LGR4/5 bind to the Furin domains, R-spondins might bridge 
between syndecans and LGR4/5 in Wnt/PCP signaling. The specificity of R-spondin and 
LGR4/5 to signal either via the Wnt/β-catenin or the Wnt/PCP signaling pathway may be 
defined by the availability of Wnt/FZD or syndecan receptors.  
5.3.3 Signaling mechanism of LGR4 and LGR5 
Although the receptors for R-spondins were identified and their effect on Wnt/β-catenin 
and Wnt/PCP signaling was characterized, the exact mechanism of how R-spondins 
enhance Wnt signaling via LGR4, LGR5 and LGR6 remained to be determined.  
LGR4/5/6 receptors were initially shown to interact with LRP5/6 and FZD5/7 in the Wnt 
signaling complex, and were thus thought to enhance receptor activity.171,174 However, it 
was found more recently that R-spondins increase membrane levels of LRP6 and 
Frizzled.175,176 The cell-surface transmembrane E3 ubiquitin ligase zinc and ring finger 3 
(ZNRF3) and its close homolog ring finger protein 43 (RNF43) were shown to associate 
with the Wnt receptor complex and promote the degradation of LRP6 and FZD, thereby 
inhibiting Wnt signaling. R-spondins bind to ZNRF3 and RNF43 and induce their 
association with LGR4/5. Because LGR4 and LGR5 are rapidly internalized, the 
interaction of ZNRF3/RNF43 with LGR4/5 through R-spondins thus results in their 
membrane clearance (Figure 15). Consequently, in the presence of R-spondins LRP6 and 
FZD receptors accumulate at the plasma membrane and enhance not only Wnt/β-
catenin but also Wnt/PCP signaling.175,176 This mechanism provides an elegant 
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explanation why R-spondins require the presence of Wnts to potentiate Wnt 
signaling.79,80,82     
 
 
Figure 15| Model of ZNRF3 function in Wnt signaling and its inhibition by R-spondin. In the absence of R-
spondin, the transmembrane E3 ubiquitin ligase ZNRF3 associates with the Wnt receptor complex and 
ubiquitinates Frizzled. This results in degradation of Frizzled and LRP6 and inhibition of Wnt/β-catenin and 
Wnt/PCP signaling. R-spondin (RSPO) binds to LGR4/5 and ZNRF3 and thereby induces the formation of a 
ternary complex, which is subsequently internalized. The removal of ZNRF3 via R-spondin leads to the 
accumulation of Frizzled and LRP6 at the membrane level and enhances Wnt/β-catenin and Wnt/PCP 
signaling. Figure modified from Hao et al., 2012.
175
 
 
The structural analysis of the ternary LGR5-RSPO1-RNF43 complex confirmed the 
physical linkage between the three proteins.177 The Cys-rich domain of RSPO1 provides 
two separate regions, which form distinct binding sites for LGR5 and RNF43. Whereas 
the first furin domain is involved in RNF43 binding, the second furin domain mediates 
binding to LGR5. The affinity of RNF43 and RSPO1 is increased when RSPO1 is bound by 
LGR5, suggesting a stabilization of RSPO1 in a configuration more favorable for RNF43 
binding. Consequently, LGR5 serves as an engagement receptor, recruiting R-spondins to 
RNF43, whereas RNF43 acts as the effector receptor.177 A similar mechanism was also 
described for LGR4/ZNRF3.178,179  
In summary, we and others have shown that R-spondins potentiate Wnt signaling via 
LGR family receptors. This interaction has important implications for development, 
shown here, as well as stem cell maintenance. It explains for the first time why R-
spondins promote the growth of stem cells, especially in the intestine,87 and why 
addition of R-spondin is required to allow long-term culturing and organoid formation of 
LGR5 positive mouse intestinal crypt stem cells in vitro.180   
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6. Chapter 2: RAB8B is required for Wnt/β-catenin signaling in Xenopus 
6.1 Introduction 
6.1.1 The family of Rab GTPases 
Rab proteins belong to the superfamily of Ras GTPases. They constitute the largest 
family of small GTPases, which act as organizers of almost all membrane trafficking 
processes in eukaryotic cells. For instance, Rab GTPases regulate signaling of many 
hormone and growth factor receptors by mediating their trafficking to lysosomes for 
degradation, or endosomes to relay downstream signaling.181 In humans, more than 60 
different members of the Rab family have been described, which differ in their 
intracellular membrane localization.182-184 Rab GTPases control the activation and 
localization of various interacting molecules, including sorting adaptors, tethering 
factors, kinases, phosphatases, coat components and motor proteins. Characterization 
of approximately half of the known Rab GTPases shows that Rab GTPases, besides their 
known role in vesicle trafficking, are also involved in signaling, cell differentiation and 
proliferation (reviewed in Stenmark, 2009181). 
Interaction of Rab GTPases with their effector molecules depends on the conformational 
state of the Rab GTPases, which alternates between a GTP-bound (active) form and a 
GDP-bound (inactive) form. Interaction of Rab GTPases and the different effector 
proteins only takes place in the active state. Through hydrolysis of the bound GTP, Rab 
GTPases are converted back to their inactive form. This occurs through intrinsic GTPase 
activity, or can be catalyzed by a GTPase-activating protein (GAP). Subsequently, Rab 
GDP is recognized by a guanine nucleotide exchange factor (GEF), which catalyzes the 
exchange of GDP by GTP. This converts the Rab GTPase back to the active state, where 
the cycle can start again (Figure 16). Thus, Rab GTPases act as molecular switches that 
impose temporal and spatial regulation on membrane transport, based on their 
respective state. 
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Figure 16| Activation cycle of Rab proteins. The active, GTP-bound form of Rab GTPases is recognized by 
multiple effector proteins. The hydrolysis of GTP induces a conformational change and the release of 
inorganic phosphate (Pi). Thereby Rab proteins are converted from an active to an inactive, GDP-bound 
state. This process can be catalyzed by GTPase-activating proteins (GAP). The conversion back to the 
active conformation requires exchange of GDP by GTP, which can be catalyzed by guanine nucleotide 
exchange factors (GEF). Figure modified from Stenmark, 2009.
181
 
 
6.1.2 Rab GTPase RAB8 
In mammals, two RAB8 isoforms, known as RAB8A and RAB8B have been described, 
which differ substantially in their C-terminal region and expression pattern.185,186 Both 
proteins are activated by RABIN8, a GEF that seems to be specific for RAB8, as it does 
not activate other Rab family members.187,188 The activation of RAB8A and RAB8B via 
RABIN8 is facilitated by another member of the Rab family, RAB11.189,190 Originally, RAB8 
was described to mediate the trafficking of newly synthesized proteins from the trans-
Golgi network (TGN) to the plasma membrane.181 Besides protein shuttling, RAB8A and 
RAB8B participate in various other membrane-based pathways, like exocytosis, 
membrane recycling, neuron differentiation and ciliogenesis.191 Furthermore, RAB8 is 
involved in the regulation of cell migration and cell morphogenesis by connecting actin 
dynamics to membrane trafficking and turnover.192,193 RAB8 was found to be up-
regulated in mammary tumors and their lymph node metastases.194 This is probably 
linked to the finding that RAB8 regulates polarized exocytosis of a matrix 
metalloproteinase involved in cell invasion.195  
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Endocytosis also plays an important role in Wnt/β-catenin signal transduction. After 
binding of Wnts, the ligand-receptor complex undergoes internalization via clathrin or 
caveolin-dependent routes.95 However, the mechanism of Wnt signal transmission, 
notably how endocytosis of the Wnt receptors is regulated, remains incompletely 
understood. It has been suggested that the localization of LRP6 in the different 
microdomains of the plasma membrane could be regulated by proteins, which link LRP6 
to the endocytic machinery.107 The identification of proteins involved in the endocytosis 
process of the Wnt receptors could give new insights into the specificity of the endocytic 
processes and the regulation of Wnt signaling.  
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6.2 Results 
In an RNAi screen aimed at identifying regulators involved in trafficking of Wnt pathway 
components, the small GTPase RAB8B was identified as a candidate protein in the 
Boutros laboratory. Based on experiments performed by Kubilay Demir in the laboratory 
of Prof. M. Boutros, RAB8B is required for Wnt/β-catenin signaling in mammalian cells. 
To analyze if RAB8B is also required for Wnt/β-catenin signaling in vivo, the role of 
RAB8B in Xenopus embryos was examined.   
In order to analyze the effect of RAB8B on Wnt/β-catenin signaling in Xenopus, two 
antisense Morpholino oligonucleotides (Mo) were designed, targeting distinct regions of 
RAB8B. Injection of either Morpholino gave rise to similar phenotypes in Xenopus 
tadpoles, suggesting a specific effect on RAB8B. RAB8B morphants were characterized 
by shortened body axes, smaller heads and eyes and a reduction in eye pigmentation 
and melanocytes (Figure 17A). This phenotype resembles conditions in which Wnt/β-
catenin, as well as Wnt/PCP signaling are dysregulated.22,196 To confirm the requirement 
of RAB8B for Wnt signaling in Xenopus on the molecular level, TOPFlash reporter assays 
for Wnt/β-catenin signaling were performed. On the endogenous level, both 
Morpholinos reduced the reporter activity in a dose-dependent manner, further 
corroborating their specificity (Figure 17B,C). This decrease in luciferase activity 
resembled loss of LRP6. Moreover, when Wnt/β-catenin signaling was stimulated by co-
injection of WNT3A mRNA, increased reporter activity was fully blocked by RAB8B Mo2 
(Figure 17C). Taken together, these results strongly suggest a positive role of RAB8B in 
Wnt/β-catenin signaling in Xenopus embryos. 
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Figure 17| RAB8B is required for Wnt/β-catenin signaling in Xenopus. (A) RAB8B Morpholino 1 (Mo1) 
and Morpholino 2 (Mo2) display similar phenotypes in X.laevis. Embryos were injected equatorially at 4-
cell stage with 40 ng Mo1 and 60 ng Mo2 and the corresponding control Mo (co). (B-C) TOPFlash reporter 
activity is reduced by RAB8B Mo1/2 in Xenopus. Embryos were injected equatorially at 4-cell stage with 
TOPFlash reporter (100 pg) and Renilla reporter plasmids (25 pg) and the indicated Morpholinos (5 ng, 
10 ng, 20 ng, 40 ng RAB8B Mo1, 10 ng, 20 ng, 40 ng, 60 ng RAB8B Mo2, 2.5 ng LRP6 Mo) and WNT3A 
mRNA (4 pg). Corresponding amounts of control Mo and control mRNA were injected. Luciferase reporter 
assays were performed from whole embryos at stage 11. Luciferase activity of embryos injected with co 
Mo was set to 100%. RLA, relative luciferase activity. Graphs show mean ± SD, N=3. Figure from Demir et 
al., 2013.
197
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6.3 Discussion  
6.3.1 RAB8B is required for Wnt/β-catenin signaling in vivo 
RAB8B was identified as a regulator of Wnt/β-catenin signaling in mammalian cells.197 
Because Wnt signaling plays major roles during the development of Xenopus embryos, 
this model organism is well suited to investigate putative Wnt pathway regulators in 
vivo.  
In Xenopus embryos, RAB8B is already present as maternal RNA, indicating an early 
function during Xenopus development.198 The loss-of-function phenotype of RAB8B in 
Xenopus is characterized by axis, head and pigmentation defects, which resembles 
Wnt/β-catenin and Wnt/PCP signaling defects described earlier.22,196 The requirement of 
RAB8B for Wnt signaling in vivo was additionally confirmed in zebrafish embryos.197 In 
contrast to Xenopus, the expression of RAB8B in zebrafish was first detectable in the 
brain of embryos at somitogenesis. Knockdown of RAB8B in zebrafish decreased target 
gene c-myc and reporter protein expression in transgenic Wnt/β-catenin reporter lines. 
Taken together, these results indicate a conserved regulatory role of RAB8B during 
vertebrate development.    
6.3.2 RAB8B promotes caveolar endocytosis of LRP6 
To investigate the molecular mechanism of RAB8B, Demir et al. examined the effect of 
RAB8B in mammalian cells.197 The effect of RAB8B is specific for Wnt/β-catenin signaling, 
as no other signaling pathways were affected, and the paralog RAB8A did not have an 
impact on Wnt/β-catenin signaling. Furthermore, these authors found that RAB8B 
promotes caveolin-dependent endocytosis of LRP6. In response to WNT3A, LRP6 
undergoes internalization in lipid raft domains, mediated by caveolin. In contrast, DKK1 
removes LRP6 from lipid raft domains and induces endocytosis based on clathrin-
dependent routes.107 It has been proposed that the localization of LRP6 in raft and non-
raft domains could be regulated by proteins, which link LRP6 to the endocytic 
machinery.107 The small GTPase RAB8B could thus serve as a regulator of caveolin-
mediated LRP6 internalization. 
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RAB8B was recently shown to interact with TANK-binding kinase 1 (TBK-1) during the 
maturation of autophagosomes.199 Because TBK-1 was shown to associate with the 
ESCRT-I complex,200 which is involved in sorting of membrane receptors into MVBs, 
RAB8B may be involved in trafficking of the Wnt receptor complex to MVBs via its 
interaction with TBK-1. However, because the interaction of RAB8B and TBK-1 was only 
analyzed in the context of antimicrobial defense, this hypothesis requires further 
investigation.  
Interestingly, Demir et al. additionally demonstrated that the activity of RAB8B seems to 
be regulated by Wnt signaling: Recruitment of DVL1 after formation of the ternary 
receptor complex activates RAB8B, and Wnt ligands induce the interaction of RAB8B 
with its activator RABIN8.197 A similar mechanism was suggested for RAC1, a member of 
the Rho family of small GTPases.201 Whereas RAC1 promotes the nuclear translocation of 
β-catenin, its activity is in turn regulated by the Wnt signaling pathway. These 
observations suggest that a feed-forward loop from Wnt signaling to small GTPases 
potentiates Wnt signaling, through regulation of receptor trafficking. 
In conclusion, we have identified RAB8B as a novel agonist of Wnt/β-catenin signaling, 
which promotes Wnt activity by facilitating endocytosis of LRP6 signalosomes (Figure 
18). The specific function(s) of RAB8B in vivo are poorly understood, but based on the 
results shown here it can be assumed that RAB8B-dependent Wnt signaling control is 
essential for development. 
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Figure 18| Model of RAB8B function in Wnt/β-catenin signaling. After binding of Wnt to Frizzled and 
LRP6, the receptors accumulate in caveolae and recruit the β-catenin destruction complex, consisting of 
Axin, APC, CK1α, GSK3 and DVL. At the same time, RAB8B is translocated to the membrane and activated 
in a Wnt- and DVL-dependent manner. RAB8B enhances signalosome formation and/or maturation and 
promotes LRP6 activity, which results in caveolin-dependent internalization of the receptor complex and 
activation of downstream signaling. Figure modified from Demir et al., 2013.
197
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7. Chapter 3: ANGPTL4 binds syndecan and inhibits Wnt/β-catenin 
signaling by decreasing LRP6 levels 
7.1 Introduction 
7.1.1 Angiopoietin-like 4 
Angiopoietin-like 4 (ANGPTL4) was initially identified as a peroxisome proliferator-
activated receptor (PPAR) target gene with structural similarity to angiopoietins 
(ANG).202-204 Besides ANGPTL4, seven other members of this family have since been 
discovered (ANGPTL1-8, Figure 19), most of which show little structural homology.205-207 
Indeed, ANGPTL4 shares just 30% sequence identity with its closest family member, 
ANGPTL3.208 
 
 
Figure 19| Phylogenetic relationship of Angiopoietin-like family members. In humans the angiopoietin-
like (ANGPTL) family contains seven members, which share sequence homology to the angiopoietins 
(ANG), which comprise five members. The eighth member of the ANGPTL family is not shown, as it lacks 
the conserved fibrinogen-like domain, which is shared by ANG and ANGPTL proteins. Figure modified from 
Tan et al., 2012.
209
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Most ANGPTL proteins consist of a signal peptide directing secretion, an amino-terminal 
coiled-coil domain (CCD), a linker region, and a large carboxy-terminal fibrinogen-like 
domain (FLD), which is conserved in the ANG and ANGPTL families.210 An exception to 
this domain organization is ANGPTL8, which lacks the fibrinogen-like domain.206,207 In 
contrast to all other members of the ANGPTL family, only ANGPTL4 and ANGPTL3 
assemble into oligomeric structures.211,212 The full length ANGPTL4 protein (flANGPTL4) 
forms dimers or tetramers prior to secretion, through disulfide bond formation in the N-
terminal domain.211,213 In contrast, the oligomerization of ANGPTL3 requires no 
intermolecular disulfide bonds.214 After secretion of ANGPTL4 into the extracellular 
space, the full length form can bind to the extracellular matrix (ECM) via its CCD. It was 
shown in vitro that this interaction is mainly mediated by heparan and dermatan 
sulfates.215 The release of ANGPTL4 from the ECM results in proteolytic cleavage in the 
linker region, which gives rise to an N-terminal (nANGPTL4) and a C-terminal (cANGPTL4) 
fragment (Figure 20).211,215,216 This cleavage at the -RRXR- consensus cleavage site is 
mediated by pro-protein convertases.215,216 The N-terminal CCD remains multimerized, 
and binds to the extracellular matrix, whereas the C-terminal FLD is released into the 
medium as a monomer.211,215  
 
 
Figure 20| Domain organization of ANGPTL4. The structure of the human full length ANGPTL4 protein 
consists of an amino terminal, hydrophobic signal peptide (SP), a coiled-coil domain, a linker region and a 
carboxy terminal fibrinogen-like domain. After secretion, the protein can undergo proteolytic processing 
by pro-protein convertases in the linker region at conserved basic residues (-RRKR-). This results in the 
formation of nANGPTL4 and cANGPTL4 fragments. Figure modified from Tan et al., 2012.
209
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This cleavage has only been observed for ANGPTL4 and ANGPTL3, and thus distinguishes 
these two proteins from the other family members.211,212 The cleavage of ANGPTL4 
appears to be tissue and species-specific. In humans, only full length ANGPTL4 is found 
in adipose tissue, whereas the protein undergoes cleavage in mouse adipocytes.217 
Abundant ANGPLT4 cleavage was also observed in the liver, and both the full length and 
cleaved forms can be found in blood plasma.217 The expression of ANGPTL4 can be 
induced by different factors. During fasting the synthesis and secretion of ANGPTL4 is 
increased, which is mediated by glucocorticoids. This steroid hormone is induced under 
fasting conditions and activates its receptor, which elevates the expression of 
ANGPTL4.218 Similarly, chronic caloric restriction or the accumulation of free fatty acids 
stimulates nuclear hormone receptors of the PPAR family. These receptors bind PPAR-
response elements in the promoter region of ANGPTL4 and activate its 
transcription.203,219-221 Furthermore ANGPTL4 expression can be induced by hypoxia via 
hypoxia-inducible factor-1α (HIF-1α), which binds to a recognition site upstream of the 
ANGPTL4 gene.222,223 Moreover, it was recently shown that ANGPTL4 expression can be 
also regulated by the TGFβ/SMAD3 signaling pathway.224  
Although ANGPTL4 is known to undergo proteolytic processing, the biological 
importance of this process and the function of the different fragments remain elusive.209 
Furthermore, the identity of ANGPTL4 binding partner(s) is still unknown. Even though 
ANGPTL proteins are structurally related to ANGs, they do not bind the prototypical 
angiopoietin receptors TIE1 and TIE2.202 It was shown that cANGPTL4 can associate with 
integrins, whereas nANGPTL4 interacts with HSPG.215,225 These components of the ECM 
cannot explain all molecular functions of ANGPTL4, and are likely co-receptors of 
ANGPTL4. Recently it was shown that ANGPTL2 and ANGPTL5 can bind the immune-
inhibitory receptor human leukocyte immunoglobulin-like receptor B2 (LILRB2).226 As 
ANGPTL4 showed no binding to this receptor, it is still considered an orphan ligand.  
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7.1.2 Physiological functions of ANGPTL4 
ANGPTL4 has primarily been described as a regulator of lipid metabolism.227,228 It 
suppresses the clearance of circulating triacylglycerols (TAGs) by inhibiting lipoprotein 
lipase (LPL), the enzyme which hydrolyzes TAGs in lipoprotein particles.208,229,230 The N-
terminal domain of ANGPTL4 binds to LPL and converts the active LPL dimer into inactive 
monomers.216,231 This inhibitory effect is enhanced if nANGPTL4 exists as an oligomer, 
and indeed, mutations that prevent oligomerization severely reduce the ability of 
ANGPTL4 to inhibit LPL.232 ANGPTL4 expression is induced during fasting, and thus 
ANGPTL4 can act as a sensor for energy homeostasis by inhibiting LPL activity.  
Conversely, ANGPTL4 expression is enhanced by free fatty acids, which could protect the 
cell from cellular lipid overload by reducing the hydrolysis of TAGs and subsequent fatty 
acid uptake.221 Increased uptake of saturated fatty acids is typically associated with a 
stimulation of inflammation- and immunity-related factors, and macrophages in 
particular are protected from this pro-inflammatory effect via expression of ANGPTL4, 
which decreases the release of fatty acids.233 
In addition to energy homeostasis and inflammation, ANGPTL4 plays a regulatory role 
during wound healing.225,234 After skin injury, several processes are involved to facilitate 
wound closure, including cell migration, proliferation, and remodeling of the 
extracellular matrix.235 It was shown that flANGPTL4 and cANGPTL4 are expressed by 
keratinocytes adjacent to the wound and coordinate cell-matrix communication during 
the re-epithelialization process. This involves the interaction of ANGPTL4 with 
vitronectin and fibronectin in the wound bed, delaying their degradation by matrix-
metalloproteinases. Thereby the availability of extracellular matrix components is 
increased, which enhances cell-matrix interaction. In addition, cANGPTL4 interacts with 
β1 and β5-integrins to activate integrin-mediated signaling, internalization and 
keratinocyte migration.225,234     
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7.1.3 ANGPTL4 in tumorigenesis and angiogenesis 
Tumor tissue RNA micro-arrays revealed an increase in ANGPTL4 expression in several 
human epithelial tumors.236 The expression level of ANGPTL4 correlates with tumor 
progression from a benign to a metastatic state.237 An essential feature of tumor cells is 
the loss of dependence on integrin-mediated ECM contact for growth.238 The interaction 
of cANGPTL4 with β1 and β5-integrins on tumor cells was shown to activate the 
production of reactive oxygen species (ROS), which induce a pro-survival signal 
independent of cell-cell or cell-matrix contacts. Thus, ANGPTL4 confers anoikis 
resistance to tumor cells.236 The inhibition of ANGPTL4 induces tumor cell apoptosis, 
highlighting the importance of ANGPTL4 for cancer therapy.236,239  
The formation of new blood vessels through release of angiogenic factors ensures the 
supply of necessary nutrients and growth factors for tumor progression. Furthermore 
they allow dissemination of cancer cells throughout the body and the formation of 
metastases in distant organs.238 The communication of tumor cells with the surrounding 
endothelium is crucial for these processes and involves the production of secreted 
factors such as vascular endothelial growth factor (VEGF) and ANG.240  
The role of ANGPTL4 in angiogenesis and vascular permeability remains controversial. 
Some studies proposed an anti-angiogenic function of ANGPTL4, as it inhibits 
proliferation and tubule formation of endothelial cells.241 In addition, ANGPTL4 
decreased VEGF-induced angiogenesis and vascular leakiness and tumor growth in the 
dermal layer of transgenic mice.242 In a hypoxic environment, ECM-bound flANGPTL4 
inhibits endothelial cell motility, sprouting and tubule formation.241 ANGPTL4 also 
prevents metastasis by inhibiting vascular permeability, as well as tumor cell motility 
and invasiveness.243 In gastric cancers, ANGPTL4 was shown to suppress tumor 
formation by inhibition of angiogenesis.244 Interestingly, an ANGPTL4 mutant that carries 
a deletion mutation in the CCD was not able to inhibit angiogenesis, indicating that this 
domain is required for the inhibitory effect. Accordingly, in human gastric cancers an 
accumulation of the deletion mutant was found.244  
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However, a pro-angiogenic function of ANGPTL4 was observed in other studies. In in 
vitro assays ANGPTL4 induced angiogenesis and rearrangement of blood vessels, and its 
expression was significantly increased in tumor cells from clear cell renal cell 
carcinomas.245 Similarly, ANGPTL4 mRNA levels are up-regulated in human gastric and 
colorectal cancer, where ANGPTL4 was found to promote venous invasion.237,246 In 
Kaposi’s sarcoma, a highly vascular tumor induced by human herpesvirus-8 infection, 
enhanced ANGPTL4 expression is thought to facilitate angiogenesis and vascular 
permeability and thereby promote tumorigenesis.247 In addition, ANGPTL4 was 
identified as one of several genes that mediate breast cancer metastasis to the 
lung.224,248 It was shown that TGFβ, which is secreted by the tumor microenvironment 
under hypoxic conditions, induces the expression of ANGPTL4 in a SMAD3-dependent 
manner. Tumor cell-derived ANGPTL4 disrupts vascular endothelial cell-cell junctions 
and increases the permeability of lung capillaries. This facilitates the trans-endothelial 
passage of breast tumor cells to selectively seed lung metastasis.224 Mechanistically, 
cANGPTL4 interacts with and activates the α5β1-integrin signaling pathway to weaken 
cell-cell contacts. Additionally, cANGPTL4 associates with vascular endothelial cadherin 
and claudin 5 and induces their dissociation and internalization. Both processes 
converge in endothelial disruption and facilitate lung metastasis in mice.249  
The above observations show that the biological functions of ANGPTL4 and their 
underlying molecular mechanisms are incompletely understood. In particular, the 
specific roles of the ANGPTL4 cleavage fragments are largely unknown, and require 
further investigation. Moreover, to fully elucidate ANGPTL4 signaling, it will be critical to 
identify ANGPTL4 interactors and receptors that mediate its diverse biological effects.   
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7.1.4 Development and regulation of notochord formation in Xenopus 
The development of axial structures in vertebrates is induced during gastrulation by the 
organizer region. In amphibian embryos, the organizer can be subdivided into a head 
and a trunk organizer.250 Whereas the head organizer induces anterior fates in the 
overlying ectoderm, the trunk organizer mediates neural induction in dorsal ectoderm, 
as well as dorsalization of equatorial mesoderm.251 Besides its ability to organize 
surrounding tissue, the head or trunk organizers undergo differentiation and give rise to 
head tissue, such as the prechordal plate or the notochord, respectively. The notochord 
itself acts as a signaling center, which is required for patterning of surrounding 
tissues.252,253 The development of the presumptive notochord region requires the 
inhibition of both BMP and Wnt/β-catenin signaling.254  
In Xenopus, wnt8 is expressed in the ventral marginal zone during gastrulation.255,256 It 
was shown that Xenopus Wnt8 enhances the expression of myogenic genes, such as 
myoD and myf5, whereas it inhibits the expression of the notochord marker gene 
Xnot.257-259 Consequently, ectopic expression of wnt8 in dorsal mesoderm of Xenopus 
embryos changes the fate of dorsal cells (head mesoderm, notochord) to more lateral 
tissue (somatic muscle).257 Thereby Wnt8 has a function in patterning the marginal zone, 
and it was proposed that Wnt8 may position the notochord/somite boundary.259 This, 
however, requires the expression of Wnt inhibitors in the presumptive notochord 
region, which allow Xnot expression and thereby notochord formation. It was shown 
that the expression of goosecoid (gsc) inhibits wnt8 expression on the transcriptional 
level. Furthermore gsc induces the expression of frzb, which is secreted from the 
prechordal plate and inhibits wnt8 through direct binding (Figure 21). These two 
mechanisms exclude Wnt8 from the presumptive notochord region and allow the 
expression of Xnot.254,257    
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Figure 21| Model of notochord formation during Xenopus development. The induction of notochord 
formation requires inhibition of BMP signaling in somitic (yellow) and notochord (red) regions. In addition, 
Wnt signals have to be blocked in the presumptive notochord tissue. This is facilitated by secretion of Wnt 
inhibitors like Frzb from the prechordal plate. Frzb expression is regulated by goosecoid (gsc). The 
inhibition of both pathways allows the expression of the notochord marker Xnot and thereby the 
development of the notochord. Figure modified from Yasuo & Lemaire, 2001.
254
 
 
Thus, maintenance of notochord development requires inhibition of Wnt/β-catenin 
signaling, through expression and secretion of specific Wnt inhibitors like Frzb. 
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7.2 Results 
To identify novel Wnt pathway components regulating Wnt signaling, we performed a 
genome-wide small interfering RNA (siRNA) screen.22 The transcription of a Wnt-
responsive luciferase reporter construct was analyzed after stimulation with six different 
Wnt activators. In this screen, ANGPTL4 was identified as a putative negative regulator 
of Wnt signaling (Table 1). Compared to all other ANG and ANGPTL proteins covered by 
this screen, only ANGPTL4 depletion resulted in high z-scores (>3) after stimulation of 
the Wnt luciferase reporter with either WNT3A conditioned medium or transfection of 
WNT1, FZD8, LRP6. 
 
Table 1: ANGPTL4 is a negative regulator of Wnt signaling. Angiopoietin (ANG) and Angiopoietin-like 
(ANGPTL) proteins sorted according to their z-scores in the genome-wide siRNA Wnt luciferase reporter 
assay in HEK293T cells, stimulated by transfection of the ternary WNT1+FZD8+LRP6 complex. The list 
contains only candidates with low z-score in the cell viability screen. Z-scores from Wnt luciferase reporter 
screens activated with WNT3A-/RSPO3-conditioned medium or by transfection with β-catenin, WNT1, 
RSPO3 and LRP6ΔE1-4 constructs are also indicated. siRNA screen was performed by Cristina Cruciat and 
data analysis by Dierk Ingelfinger.
22
 Z-scores indicate the strength of each siRNA. Strong siRNA effects are 
resembled by a large positive or negative z-score.
260
 
WNT3A RSPO3 β-catenin Viability 
WNT1
+ 
RSPO3 
WNT1 
+FZD8 
+LRP6 
LRP6
∆E1-4 
Gene-ID Gene 
Name 
3.58 2.9 1.52 -1.31 1.65 3.24 2.06 NM_016109 ANGPTL4 
-0.65 -0.28 1.59 0.15 0.99 1.49 0.82 NM_015985 ANG4 
0.08 0.07 0.02 0.45 -0.65 1.04 0.4 NM_014495 ANGPTL3 
-0.57 -0.42 0.09 0.57 0.22 0.85 0.68 NM_001147 ANG2 
0.33 -0.08 1.25 -0.26 0.63 0.34 -0.18 NM_004673 ANGPTL1 
-0.8 0.3 -1.86 0.12 0.96 0.14 -0.57 NM_031917 ANGPTL6 
-0.08 -1.17 1.05 1.01 -0.16 -0.02 0.64 NM_001146 ANG1 
-0.71 -0.49 -3.12 1.07 0.02 -0.9 -1.6 NM_178127 ANGPTL5 
-0.73 -1.33 1.44 -0.22 -2.95 -2.17 -0.47 NM_012098 ANGPTL2 
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7.2.1 ANGPTL4 is a negative regulator of Wnt/β-catenin signaling 
To validate the results of the genome-wide siRNA screen and to analyze the effect of 
ANGPTL4 epistatically, additional Wnt reporter assays were performed. Knock-down of 
ANGPTL4 by siRNA enhanced TOPFlash reporter activity induced by a combination of 
WNT1, FZD8 and LRP6 or by WNT3A (Figure 22A). In contrast, siANGPTL4 did not 
enhance luciferase activity induced intracellularly by DVL1 or β-catenin (Figure 22A). 
Similarly, the expression of the canonical Wnt target gene AXIN2 was enhanced in 
siANGPTL4 transfected cells, further confirming the inhibitory role of ANGPTL4 (Figure 
22B). The siANGPTL4 effect on TOPFlash reporter activity was rescued by the addition of 
ANGPTL4 conditioned medium, whereas DKK3 conditioned medium had no effect, 
attesting specificity (Figure 22C).  
The accumulation of cytoplasmic β-catenin and the phosphorylation of LRP6 are 
immediate, transcription-independent read-outs for activated Wnt signaling. Consistent 
with results from the TOPFlash assays, knock-down of ANGPTL4 led to an increase in β-
catenin, phospho- and total LRP6 protein levels in unstimulated as well as in WNT3A-
treated cells (Figure 22D, E). These results indicate an inhibitory effect of ANGPTL4 on 
Wnt/β-catenin signaling. Furthermore siANGPTL4 increased total LRP6 protein levels 
(Figure 22E), suggesting that the mechanism of ANGPTL4 in Wnt signaling could be via 
negative regulation of LRP6 production, maturation, trafficking or stability. 
As ANGPTL4 belongs to a family of eight ANGPTL proteins, the effect of other family 
members on the Wnt pathway was also investigated. Knock-down of ANGPTL3 and 
ANGPTL5 using siRNA had no effect on TOPFlash reporter activity (Figure 22F), indicating 
that the inhibitory function on Wnt/β-catenin signaling is specific for ANGPTL4. 
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Figure 22| ANGPTL4 is a negative regulator of Wnt/β-catenin signaling. (A) TOPFlash assay in HEK293T 
cells treated as indicated. Graphs show mean ± SD, N=3. Co, control. RLA, relative luciferase activity. (B) 
qPCR analysis of AXIN2 in HepG2 cells. Cells were transfected with the indicated siRNAs and stimulated 
with WNT3A-conditioned medium for 24h. (C) TOPFlash assay in HEK293T cells. ANPTL4, but not, DKK3 
conditioned medium rescued loss of ANGPTL4. (D,E) Western blot analysis of endogenous β-catenin, 
phospho (Sp1490) and total LRP6, using cytosolic (D) and membrane (E) fractions of H1703 cells. Cells 
were treated with control or WNT3A-conditioned medium in the presence of the indicated siRNAs. (F) 
TOPFlash assay in HEK293T cells transfected with the indicated siRNAs. Graphs show mean ± SD, N=3. Co, 
control. RLA, relative luciferase activity. 
 
Due to the comparatively low expression level of ANGPTL4 in HEK293T cells, the effect 
of siANGPTL4 was also analyzed in the non-small cell lung cancer lines H1299 and H1703, 
which display higher protein levels of ANGPTL4 and LRP6 and should therefore be 
sensitized to loss of ANGPTL4 (Figure 23A, and data not shown). Indeed, TOPFlash 
reporter activity was increased 4- to 8-fold compared to 2.5-fold in HEK293T cells after 
depletion of ANGPTL4, despite comparable knock-down efficiency (Figure 23B-D). These 
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results indicate that ANGPTL4 is an inhibitor of Wnt/β-catenin signaling, acting upstream 
or at the level of the Wnt receptors. 
 
 
Figure 23| The inhibitory effect of ANGPTL4 is stronger in cells with higher LRP6 levels. (A) Western blot 
analysis of endogenous LRP6 (T1479) in HEK293T, H1703 and H1299 cells. ERK1/2 was used for 
normalization. (B-D) Wnt luciferase reporter assays in HEK293T (B), H1703 (C) and H1299 (D) cells 
stimulated with WNT3A-conditioned medium, in the presence of the indicated siRNAs. Graphs show mean 
± SD, N=3. Co, control. RLA, relative luciferase activity.  Knock-down efficiency was determined by qPCR, 
shown in the graphs on the right. 
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7.2.2 ANGPTL4 inhibits TGFβ/Smad signaling in vitro   
To investigate whether ANGPTL4 knock-down also affects other signaling pathways, 
specific reporter constructs for the TGFβ/SMAD2, BMP/SMAD1 and FGF signaling 
pathways were analyzed. TGFβ signaling was strongly enhanced after ANGPTL4 siRNA 
transfection (Figure 24A). This siRNA effect was specific, as Xenopus ANGPTL4 was able 
to rescue the effect dose-dependently (Figure 24B). The induction of TGFβ signaling was 
associated with increased phosphorylation of SMAD2, as shown by Western blot analysis 
(Figure 24C). For BMP signaling, a decrease in BMP reporter activity was observed after 
ANGPTL4 knock-down (Figure 24D). In contrast, FGF signaling was not affected by loss of 
ANGPTL4 (Figure 24E). These results indicate an inhibitory function of ANGPTL4 not only 
on Wnt/β-catenin but also TGFβ/SMAD2 signaling.   
To analyze whether ANGPTL4 affects Wnt/β-catenin and TGFβ signaling also in vivo, the 
role of ANGPTL4 in Xenopus was investigated. 
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Figure 24| ANGPTL4 is an inhibitor of TGFβ signaling. (A,B) TGFβ/SMAD2 luciferase reporter assays in 
HepG2 cells. Cells were transfected with ARE-luc reporter/FAST1, the indicated siRNAs, xANGPTL4 DNA 
(B), and stimulated with recombinant human TGFβ1 (2 ng/ml) for 2h. (C) Western blot analysis of 
phosphorylated SMAD2 (pSMAD2) and total SMAD2/3 after transfection with control or ANGPTL4 siRNA 
and stimulation with recombinant TGFβ1 (2 ng/ml) for 24h. (D) BMP/SMAD2 signaling assay using BREx4-
luc reporter stimulated with recombinant human BMP4 (10 ng/ml) for 24h. (E) FGF signaling assay using 
Gal-luc reporter and co-transfected Gal-Elk stimulated with recombinant human FGF8 (50 ng/ml) for 24h. 
Error bars indicate SDs, N=3. RLA, relative luciferase activity. 
 
7.2.3 ANGPTL4 is expressed in mesodermal tissue in Xenopus tropicalis 
The expression and function of ANGPTL4 during Xenopus development is unknown. 
Therefore, qPCR analysis and in situ hybridization were performed to characterize 
ANGPTL4 in Xenopus.  
In Xenopus embryos, ANGPTL4 showed prominent expression in mesodermal tissues, 
such as the tailbud mesoderm, eye lens, somites, pronephros and ventral blood islands 
(Figure 25A). Furthermore, sagittal sections of stage 25 embryos showed a defined 
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staining in the notochord. The expression pattern determined via in situ hybridization 
was confirmed by qPCR analysis, where highest expression of ANGPTL4 is detected in 
the mesodermal germ layer (Figure 25B). Furthermore it was shown that ANGPTL4 is 
maternally expressed at low levels, and that the expression strongly increased after 
gastrula stage (Figure 25C). These results demonstrate a distinct expression profile of 
ANGPTL4 in Xenopus embryos, with highest expression in tissues of mesodermal origin. 
 
 
Figure 25| ANGPTL4 is expressed in mesodermal tissues in X.tropicalis embryos. (A) Whole-mount in situ 
hybridization analysis of ANGPTL4 mRNA expression in Xenopus embryos at different stages. Cross-section 
of a stage-25 embryo showing ANGPTL4 expression in the notochord. Tb, tailbud mesoderm; no, 
notochord; ey, eye; pn, pronephros; so, somites; vbi, ventral blood island. (B) qPCR analysis of ANGPTL4 in 
Xenopus explants at stage 18, with strongest expression in mesodermal cells. Gene expression in whole 
embryos was set to 100%. (C) qPCR analysis of ANGPTL4 in Xenopus embryos at different developmental 
stages. Ornithine decarboxylase (odc) was used for normalization. 
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7.2.4 ANGPTL4 inhibits Wnt signaling in Xenopus and is required for notochord 
formation 
To investigate the role of ANGPTL4 on Wnt/β-catenin signaling in Xenopus, the 
expression of the Wnt target genes siamois and Xnr3 was analyzed. For this purpose two 
independent ANGPTL4 antisense Morpholino oligonucleotides (Mo1 and Mo2), targeting 
different splice sites of the ANGPTL4 pre-mRNA, were used. The injection of both 
Morpholinos resulted in similar phenotypes, characterized by small heads, shortened, 
bent body axes and defects in melanocyte and eye pigmentation (Figure 26A). This effect 
was specific because a mouse ANGPTL4 construct was able to partially rescue the 
phenotype (Figure 26A,B). Depletion of ANGPTL4 by Mo1 enhanced the expression of 
the Wnt target genes siamois and Xnr3 in Xenopus animal caps (Figure 26C, data for 
siamois not shown). This indicates that ANGPTL4 also acts as an inhibitor of Wnt/β-
catenin signaling in Xenopus. The inhibitory effect on Wnt signaling is specific, because it 
was rescued by co-injection of mouse ANGPTL4 mRNA in a dose-dependent manner 
(Figure 26C). Interestingly, the expression of high concentrations of ANGPTL4 resulted in 
a decrease of Wnt target genes, whereas the expression of low amounts of ANGPTL4 
increased siamois and Xnr3 expression (data not shown). This suggests a biphasic role of 
ANGPTL4 in Xenopus and illustrates that the concentration of ANGPTL4 used in the 
experiments is critical.  
Because the expression analysis of ANGPTL4 shows a distinct signal in the notochord, a 
region where Wnt/β-catenin signaling has to be inhibited to ensure its development, the 
impact of ANGPTL4 on notochord formation was examined. Depletion of ANGPTL4 with 
both Morpholinos reduced the expression of the notochord markers noggin and 
goosecoid (gsc) on the RNA level, similarly as observed after WNT8 mRNA injection 
(Figure 26D). In contrast, the expression of the muscle marker myf5 was increased 
(Figure 26E). These results were confirmed by in situ hybridization, where a reduction in 
the expression intensity and the expression area for collagen and chordin was detected 
in ANGPTL4 morphants (Figure 26F). Taken together, these results demonstrate that 
ANGPTL4 is an inhibitor of Wnt/β-catenin signaling in vivo and required for notochord 
formation in Xenopus.   
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Figure 26| ANGPTL4 inhibits Wnt/β-catenin signaling and is required for notochord formation in 
Xenopus. (A) Representative tadpole stage embryos injected equatorially at 2-cell stage with control (co) 
or two ANGPTL4 antisense Morpholino oligonucleotides (Mo1, Mo2) in the absence or presence of mouse 
ANGPTL4 mRNA. (B) Statistical analysis of the injected Xenopus embryos shown in panel (A). For each 
sample 20-60 embryos were analyzed, and the percentage of induced phenotypes was determined at 
stage 32. (C-E) Expression analysis in Xenopus animal caps by qPCR.  Animal caps were excised at blastula 
and harvested at gastrula (C) or neurula stage (D,E). Ornithine decarboxylase (odc) was used for 
normalization. Co Mo was set to 100%. (C) qPCR of Xenopus nodal-related 3 (Xnr3) in animal caps injected 
with WNT3A and mANGPTL4 mRNA and ANGPTL4 Morpholino (Mo1). (D,E) Analysis of noggin, gsc and 
myf5 expression in Xenopus animal caps. Embryos were injected with Activin and WNT8 mRNA and control 
(co) or two different ANGPTL4 Morpholinos (Mo1, Mo2). gsc, goosecoid; myf5, myogenic factor 5. (F) 
Whole-mount in situ hybridization analysis of collagen and chordin mRNA expression in Xenopus 
morphants at the indicated stages. Embryos were injected with control (co) or two different 
concentrations of ANGPTL4 Morpholino1 or 2 (Mo1, Mo2). 
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7.2.5 ANGPTL4 is required for mesoderm formation in Xenopus through Activin/Nodal 
signaling 
To investigate if ANGPTL4 also affects TGFβ signaling in Xenopus, the expression of 
target genes was analyzed. In animal cap explants, Xbra expression can be induced by 
different signaling pathways. The effect of ANGPTL4 on inducers of TGFβ (Nodal/Activin) 
and FGF signaling pathways was examined. Co-injection of ANGPTL4 Mo1 and Mo2 
decreased Xbra expression induced by Activin and Xnr1 (Figure 27A, B). In contrast, 
depletion of ANGPTL4, by Mo1 or Mo2, had no effect on Xbra expression induced by 
eFGF RNA (Figure 27C). This indicates that ANGPTL4 has no effect on FGF signaling, 
confirming the in vitro results. These results suggest that ANGPTL4 is required for 
Activin/Nodal, but not FGF signaling in Xenopus.  
Among other processes, Activin/Nodal signaling is involved in mesoderm formation 
during Xenopus development. Because ANGPTL is required for Activin/Nodal signaling in 
Xenopus, it is possible that ANGPTL4 is also involved in this process. To address this 
question, mesodermal markers were analyzed. The expression of the pan-mesodermal 
marker brachyury (Xbra) was decreased in ANGPTL4 morphants as shown by qPCR 
analysis (Figure 27D). Accordingly, the expression of the muscle markers myf5 and 
myoD, which develop from the mesodermal germ layer, was reduced (Figure 27E, F). 
This was confirmed by in situ hybridization of unilateral injected embryos, which showed 
a decrease in muscle actin and myf5 staining, upon knock-down of ANGPTL4 (Figure 
27G). The misregulation of critical components, required for mesoderm development, 
results in gastrulation defects in Xenopus embryos. A similar phenotype was observed 
after overexpression of either mouse or Xenopus ANGPTL4 (Figure 27H). The phenotype 
of these tadpoles is characterized by shortened embryonic axis, defects in neural tube 
closure and small heads. This indicates that ANGPTL4 is required for mesoderm 
formation in Xenopus through its effect on Activin/Nodal signaling. 
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Figure 27| ANGPTL4 is required for Activin/Nodal signaling and mesoderm formation in Xenopus. (A-C) 
Expression analysis of Xbra in Xenopus animal caps by qPCR. Xbra expression was induced by injection of 
Activin (A), Xnr1 (B) or eFGF mRNA (C). Embryos were co-injected with control (co) or ANGPTL4 
Morpholinos (Mo1, Mo2) using three different concentrations (10ng, 20ng, 40ng). Animal caps were 
excised at blastula and harvested at gastrula stage. Ornithine decarboxylase (odc) was used for 
normalization. Co Mo was set to 100%. (D-F) Expression analysis of Xbra (D), myf5 (E), and myoD (F) in 
Xenopus whole embryos by qPCR. Embryos were injected with control (co) or ANGPTL4 Morpholinos 
(Mo1, Mo2) as in (A-C). (G) Whole-mount in situ hybridization analysis of m.actin and myf5 mRNA 
expression in Xenopus morphants at different stages. Embryos were injected unilaterally with control (co) 
or ANGPTL4 Morpholino1 (Mo1) in combination with the lineage tracer β-galactosidase. Staining of β-
galactosidase (red) indicates injected site. (H) Representative tadpole stage embryos injected equatorially 
at 4-cell stage with control (ppl), mouse (mAL4) or Xenopus (xAL4) ANGPTL4 mRNAs.  
Xbra, Xenopus brachyury; Xnr1, Xenopus nodal-related 1; eFGF, embryonic fibroblast growth factor; myf5, 
myogenic factor 5; myoD, myogenic differentiation 1; m.actin, muscle actin. 
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Full length ANGPTL4 is proteolytically processed after secretion, and gives rise to an N-
terminal (nANGPTL4) and a C-terminal (cANGPLT4) fragment. To analyze which part of 
ANGPTL4 is required for mesoderm induction during Xenopus development, different 
deletion constructs were cloned (Figure 28A). In gain-of-function experiments, 
nANGPTL4 was able to induce spina bifida similar to the full length protein (Figure 28B). 
The cANGPTL4 construct, on the other hand, did not induce this phenotype (Figure 28B), 
suggesting that the C-terminal part is dispensable for the effect of ANGPTL4 on 
mesoderm formation. 
In contrast to its inhibitory effect on TGFβ signaling in vitro, ANGPTL4 is required for 
Activin/Nodal signaling and mesoderm formation in Xenopus, and this function is likely 
mediated by the N-terminal CCD domain. 
 
 
Figure 28| N-terminal domain of ANGPTL4 is sufficient to induce spina bifida in Xenopus. (A) Domain 
organization of ANGPTL4. Based on the structure of ANGPTL4 a full length (flANGPTL4), N-terminal 
(nANGPTL4) and C-terminal (cANGPTL4) construct was cloned. (B) Embryos were injected equatorially at 
4-cell stage with control (ppl), flANGPTL4, nANGPTL4 or cANGPTL4 mRNA. Phenotypes were analyzed at 
tadpole stage.  
 
 
 
 
7. Chapter 3: ANGPTL4 binds syndecan and inhibits Wnt/β-catenin signaling by decreasing LRP6 levels 
60 
 
7.2.6 ANGPTL4 binds to syndecans 
As shown above, ANGPTL4 regulates Wnt/β-catenin and TGFβ signaling in vitro and in 
vivo. To investigate the molecular mechanism by which ANGPTL4 regulates both 
signaling pathways, the identity of the interaction partner was investigated. For this 
purpose, co-immunoprecipitation (co-IP) with subsequent mass spectrometric analysis 
was performed. A total of six membrane-associated proteins were identified, including 
components of the extracellular matrix and three members of the syndecan family of 
transmembrane proteoglycans (Table 2).  
 
Table 2: Transmembrane or membrane-associated proteins identified via mass spectrometry after 
ANGPTL4 co-IP. ANGPTL4 IP was performed in HepG2 cells after addition of HRP-Str.-ProteinA-ANGPTL4 
conditioned medium for 1h. After a two-step purification process, IP samples were separated by SDS-PAGE 
and proteins were stained with Coomassie Blue. Co-precipitated proteins were analyzed by mass 
spectrometric analysis (ESI-MS/MS). Transmembrane or extracellular matrix proteins were identified 
based on gene ontology (bioDBnet). These proteins were sorted according to the number of unique 
peptides detected during MS analysis. 
Accession No. Identified protein #unique peptides 
ZO2_HUMAN Tight junction protein ZO-2 17 
FINC_HUMAN Fibronectin 10 
SDC4_HUMAN Syndecan-4 4 
LEG8_HUMAN Galectin-8 5 
SDC1_HUMAN Syndecan-1 5 
SDC2_HUMAN Syndecan-2 3 
 
As syndecans (SDC) are transmembrane proteins, and ANGPTL4 was shown to act 
epistatically at the Wnt receptor level (Figure 22), a possible direct interaction of 
ANGPTL4 and SDC was tested. In cell surface binding assays, an alkaline-phosphatase 
(AP) fusion protein of ANGPTL4 bound to cells expressing SDC1, SDC2, SDC3 and SDC4 
(Figure 29A). In contrast, no binding of ANGPTL4 to cells transfected with LGR4/5 or 
LRP6 was detected, which however bound their respective ligands, RSPO3 and DKK1 
(Figure 29A). To confirm the direct binding between ANGPTL4 and SDC, an ELISA-based 
binding assay was used. Here Strep-tagged ANGPTL4 was coupled to Streptavidin-coated 
plates and different concentrations of AP-tagged, soluble SDC4 were applied (Figure 
29B). In the tested concentration range, a near-linear correlation between bound and 
free SDC4 was observed for ANGPTL4 and the known syndecan ligand RSPO3. In 
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contrast, no binding of DKK3 to SDC4 was detected (Figure 29C). Together these results 
show that ANGPTL4 can bind all four syndecans.    
 
 
Figure 29| ANGPTL4 binds syndecans. (A) Cell surface binding assay. HEK293T cells were transfected with 
the indicated plasmids and subjected to binding assays with conditioned medium containing alkaline-
phosphatase (AP) fusion proteins of ANGPTL4, R-spondin3-ΔC (RSPO3), or DKK1. Bound ligands were 
detected with AP substrate (red). (B) Schematic model of ELISA-based in vitro binding assay. High binding 
affinity plates were coated with Streptavidin, and Strep-tagged ANGPTL4 was bound to the Streptavidin-
coated plate. After washing, different concentrations of alkaline-phosphatase (AP) fusion protein of 
SDC4∆TMC was applied. Binding of SDC4 was detected by AP measurement. Besides ANGPTL4, RSPO3∆C 
and DKK3 were used as controls. (C) ELISA-based in vitro binding assay using ANGPTL4 (blue), RSPO3∆C 
(red) and DKK3 (green). As binding was still in the linear phase, linear fitting was applied.  
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7.2.7 Syndecans mediate clathrin-dependent internalization of ANGPTL4 
A characteristic feature of syndecans is their ability to induce endocytosis upon ligand 
binding.261-264 This is essential for signal transduction, for example in FGF signaling.264 To 
investigate if ANGPTL4 undergoes endocytosis, internalization assays were performed. 
For this purpose a horseradish peroxidase (HRP) fusion protein of ANGPTL4 was used, 
which can be visualized by tyramide signal amplification. Incubation of HepG2 cells with 
HRP-ANGPTL4 at 37°C induced internalization of ANGPTL4 within 40 min. In contrast, no 
internalization was observed when cells were incubated on ice (Figure 30A). The 
treatment of cells with chlorate inhibits the sulfation of heparan sulphate chains, which 
is required for proper function of HSPGs like syndecans.265 The incubation of cells with 
chlorate completely abrogates ANGPTL4 endocytosis (Figure 30A), indicating that HSPGs 
are required for ANGPTL4 internalization. The depletion of all four syndecans, using 
siRNA mediated knock-down, also reduced ANGPTL4 internalization. Interestingly, the 
depletion of only one member of the syndecan family had no effect (Figure 30A), 
indicating that they can compensate each other. 
To determine the nature of this endocytosis process, cells were treated with inhibitors 
of clathrin and caveolin-dependent endocytosis. The clathrin inhibitor monodansyl-
cadaverine (MDC) blocked ANGPTL4 internalization, unlike inhibitors of caveolin-
mediated endocytosis, including nystatin and filipin (Figure 30B). Consistent with the 
drug treatment, depletion of clathrin by siRNA reduced ANGPTL4 cytoplasmic punctae, 
whereas siRNA targeting caveolin had no effect (Figure 30B). Conclusively, the data show 
that syndecans are required for clathrin-mediated endocytosis of ANGPTL4.  
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Figure 30| Syndecans mediate clathrin-dependent internalization of ANGPTL4. (A,B) Internalization 
assay in HepG2 cells treated for 40 min with horseradish peroxidase (HRP)-tagged ANGPTL4 on ice or at 
37°C. HRP-tagged ANGPTL4 was visualized by tyramide signal amplification (green). Nuclei were 
counterstained with Hoechst-33342 (blue). Where indicated cells were pretreated with siRNAs for 3 days 
or with 25 mM sodium chlorate for 48 h. (B) Internalization of ANGPTL4 in the presence of different 
clathrin (MDC) or caveolin (Nystatin, Filipin) specific inhibitors. Cells were treated for 1 h with the 
indicated inhibitors. DMSO was used as a control. MDC, monodansyl-cadaverin. 
 
7.2.8 ANGPTL4 binds to LRP6 likely via syndecan 
Endocytosis is an essential mechanism of receptor mediated signaling. In the case of 
Wnt signaling, the internalization of the Wnt-receptor complex is an obligatory step in 
activating downstream signaling. Syndecans were not only characterized as efficient 
inducers of endocytosis, but were also described as co-receptors of Wnt signaling in 
different organisms.78,266 Recently it was shown that syndecan 4 does not only promote 
noncanonical, but also inhibits canonical Wnt signaling.267 Syndecans could therefore 
mediate the inhibitory effect of ANGPTL4 on Wnt/β-catenin signaling. To analyze if 
syndecans have a similar function as ANGPTL4, TOPFlash reporter assays were 
performed. The reporter activity was enhanced after depletion of SDC1, similar to 
siANGPTL4 (Figure 31A). The combination of siRNA targeting ANGPTL4 and SDC1 further 
enhanced reporter activity, indicating that both cooperate in Wnt pathway inhibition.  
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Based on the synergistic effect of ANGPTL4 and syndecan, and the role of syndecans as 
Wnt co-receptors, it was investigated if ANGPTL4 binds to Wnt receptors via syndecans. 
Indeed, Flag-tagged LRP6 and Strep-tagged ANGPTL4, which was added as conditioned 
medium, can be immunoprecipitated in the presence of co-expressed haemagglutinin-
tagged SDC4 (SDC4-HA). In contrast, no interaction was observed, when control or Strep-
tagged RSPO3 conditioned media were added (Figure 31B). These results suggest that 
ANGPTL4 and syndecans synergize in Wnt/β-catenin pathway inhibition and ANGPTL4 
interacts with LRP6 in the presence of syndecan.  
 
 
Figure 31| ANGPTL4 synergizes with syndecan in Wnt/β-catenin signaling and binds to LRP6.  (A) Wnt 
luciferase reporter assay stimulated with WNT3A-conditioned medium in the presence of the indicated 
siRNAs. Co, control medium. RLA, relative luciferase activity. (B) Western blot analysis shows binding of 
ANGPTL4 to LRP6 in the presence of SDC4. HEK293T cells were transfected with SDC4-HA and LRP6-Flag, 
and Strep-tagged ANGPTL4, RSPO3 or control conditioned medium was added to cells for 1 h. After lysis of 
cells, Strep-tagged proteins were precipitated using streptavidin beads, and interacting proteins were 
examined by Western blot analysis. SDC4 and LRP6 are equally expressed in all conditions. Panel B was 
provided by Stefan Koch. 
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7.2.9 ANGPTL4 inhibits Wnt/β-catenin signaling by decreasing LRP6 levels 
Based on the interaction of ANGPTL4 with syndecans and LRP6, and the increase in total 
LRP6 levels detected after ANGPTL4 depletion (Figure 22E), ANGPTL4 may inhibit Wnt/β-
catenin signaling by affecting LRP6 levels. Biochemical assays were conducted to test this 
hypothesis. A cell-surface protein biotinylation assay was performed and LRP6 levels 
were detected by Western blot after Streptavidin-IP. Treatment with ANGPTL4 siRNA 
increased levels of cell surface LRP6, without affecting other transmembrane proteins, 
like transferrin receptor (Figure 32A). This indicates that ANGPTL4 affects LRP6 cell 
surface levels. This was confirmed by gain-of-function studies using a flow cytometry 
based approach.268 The detection of cell surface LRP6 revealed a decrease in LRP6 
surface levels after addition of ANGPTL4 conditioned medium (data not shown). To 
determine which part of ANGPTL4 is required for this effect, deletion constructs were 
generated, containing either the N-terminal or C-terminal domain. Interestingly, the 
addition of nANGPTL4 decreased cell surface LRP6, whereas cANGPTL4 had no effect 
(Figure 32B). Taken together, these results indicate that ANGPTL4 inhibits Wnt/β-catenin 
signaling by reducing LRP6 membrane levels, which requires only the N-terminal domain 
of ANGPTL4.   
 
 
Figure 32| ANGPTL4 decreases LRP6 membrane levels. (A) ANGPTL4 loss-of-function increased LRP6 cell 
surface levels as indicated by cell surface biotinylation assay. Western blot analysis of LRP6 after cell 
surface biotinylation, cell lysis (Input) and pull down of biotinylated proteins (IP) in the presence of the 
indicated siRNAs. (B) nANGPTL4 gain-of-function decreased cell surface LRP6 in FACS analysis. Flow 
cytometric analysis of membrane LRP6 in cells treated with control, C-terminal ANGPTL4 (cANGPTL4), N-
terminal ANGPTL4 (nANGPTL4) or DKK1 conditioned medium for 1 h. Figure was provided by Stefan Koch.   
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7.3 Discussion 
7.3.1 ANGPTL4 is a regulator of mesodermal differentiation in Xenopus 
ANGPTL4 has previously been described as an integral regulator of lipid 
metabolism,227,228 cell migration,225,234 and angiogenesis.242,244,246 Here I outline a new 
function of ANGPTL4 in Xenopus development. In Xenopus embryos, ANGPTL4 
expression was mainly detected in mesodermal tissue, including the notochord. The 
development of the notochord is strictly regulated and requires co-inhibition of BMP 
and Wnt signaling.254 It was shown that inhibition of Wnt/β-catenin signaling is essential 
for normal specification of axial (notochord) versus lateral (somatic) mesoderm.251,269 
Because ANGPTL4 shows prominent expression in the notochord, it was investigated 
whether depletion of ANGPTL4 affects on notochord formation. The analysis of different 
notochord markers, using both qPCR and in situ hybridization, confirmed this 
hypothesis. The knockdown of ANGPTL4 resembled overexpression of WNT8,258 which 
suggests that ANGPTL4 is an inhibitor of Wnt signaling in vivo. In contrast to the 
reduction in notochord marker gene expression, mesodermal markers were increased 
upon depletion of ANGPTL4. These data are in accordance with the observation that 
overactivation of Wnt signaling results in re-specification of the notochord as somitic 
mesoderm.257 These results demonstrate that the inhibitory effect of ANGPTL4 is of 
physiological relevance, as ANGPTL4 promotes notochord development in Xenopus, 
presumably by inhibiting Wnt signaling. It should be noted, however, that ANGPTL4 
knock-out mice are viable, although they are born at lower frequency than heterozygous 
litter mates.227 Similarly, hemizygous loss of ANGPTL4 in humans affects lipid 
metabolism, but does not result in overt developmental defects.270 It has recently been 
suggested that deleterious genetic mutations may not manifest phenotypically due to 
compensatory gene regulation.271 The striking effect of acute Morpholino-mediated 
knock-down on Xenopus notochord differentiation may therefore reflect more faithfully 
the developmental function of ANGPTL4. 
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7.3.2 ANGPTL4 inhibits Wnt/β-catenin signaling at the receptor level. 
The above results strongly suggest that ANGPTL4 regulates mesodermal differentiation 
primarily by inhibiting Wnt/-catenin signaling. Indeed, it was shown previously that 
ectopic over-expression of the prototypical Wnt antagonist DKK1 in zebrafish is sufficient 
to induce notochord enlargement.272 Similarly, it has been suggested that Frzb 
antagonizes WNT8 during Xenopus development, thereby ensuring notochord 
differentiation.254 Consistent with the concept that ANGPTL4 acts as a secreted Wnt 
inhibitor, knock-down of ANGPTL4 in vitro strongly induced Wnt signaling, and epistasis 
assays revealed that ANGPTL4 inhibits Wnt signaling at the receptor level. This function 
is unique for ANGPTL4, as no such effect was observed for ANGPTL3 and ANGPTL5.  
7.3.3 ANGPTL4 is a mediator of TGFβ signaling and regulates mesoderm formation in 
Xenopus 
Besides being a negative regulator of Wnt/β-catenin signaling, ANGPTL4 is also involved 
in the regulation of TGFβ signaling. TGFβ reporter activity was strongly enhanced in cells 
treated with ANGPTL4 siRNA. This effect is likely mediated by the SMAD2/3 pathway, as 
ANGPTL4 depletion increased SMAD2 phosphorylation. In contrast to the inhibitory 
effect of ANGPTL4 in vitro, in vivo results revealed a requirement of ANGPTL4 for 
Activin/Xnr1 induced Xbra expression. Based on preliminary studies, it appears that 
different domains of ANGPTL4 exert these divergent effects. In Xenopus embryos the N-
terminal part of ANGPTL4 is sufficient to induce spina bifida formation. It is possible, that 
TGFβ signaling in mammalian cell lines requires a different part of ANGPTL4. 
Comparatively, the in vitro experiments were performed using TGFβ1, whereas the 
Xenopus effects were investigated using Activin and Nodal ligands. Therefore another 
explanation could be that different ligands of the TGFβ family mediate the interaction of 
ANGPTL4 with different effector molecules, which induce distinct effects. Besides the 
effect on TGFβ signaling in Xenopus, ANGPTL4 seems to be required for mesoderm 
formation, as depletion reduced mesodermal markers. In the process of mesoderm 
development several pathways converge to allow formation of the three germ layers 
(reviewed in Kimelman et al., 1992273). Whereas ANGPTL4 has no effect on FGF 
signaling, it strongly affects TGFβ signaling. Therefore in Xenopus development the 
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requirement of ANGPTL4 for the process of mesoderm formation is likely mediated by 
the positive effect of ANGPTL4 on TGFβ signaling. 
Taken together, the data indicate that ANGPTL4 is not only an inhibitor of Wnt/β-
catenin, but also a mediator of TGFβ signaling in vitro and in Xenopus.    
7.3.4 ANGPTL4 binds all four syndecans 
In search for an ANGPTL4 receptor, which mediates the effects of ANGPTL4 on Wnt/β-
catenin and TGFβ signaling, syndecans were identified as a putative candidate. Besides 
syndecans, the intracellular tight junction protein ZO-2, as well as the extracellular 
matrix components fibronectin and galectin 8 were detected by mass spectrometry. 
Binding of ANGPTL4 to these proteins is likely indirect via integrins or syndecans, for 
which interaction has already been described.274-276  
By independent lines of evidence, it was shown that syndecans act as receptors or co-
receptors for ANGPTL4, including co-IP, cell surface binding, ELISA-based binding assays 
and functional cooperation. Syndecans comprise a family of four transmembrane 
proteoglycans, which act as co-receptors for different growth factors and are involved in 
cell proliferation, differentiation, adhesion, and migration.277-279  
Recent studies suggest a regulatory function of SDC2 in TGFβ signaling. It was shown 
that SDC2 impacts TGFβ signaling via direct binding of the TGFβ ligand and regulation of 
receptor expression.280,281 However, another report observed an inhibitory effect of 
SDC2 on TGFβ signaling in alveolar epithelial cells. In this background SDC2 promotes 
caveolin-dependent internalization of ligand (TGFβ) and receptor (TGFβRI), thereby 
inhibiting TGFβ signaling.282 These different effects of SDC2 on TGFβ signaling are in line 
with a biphasic effect of SDC1 on BMP signaling in Xenopus embryos.283 Based on the 
regulatory role of syndecan in TGFβ signaling, it is possible that ANGPTL4 exerts its effect 
on TGFβ signaling via syndecans. The requirement of the N-terminal domain of ANGPTL4 
for spina bifida induction in Xenopus is in line with this, as interaction of ANGPTL4 with 
HSPG is mediated by a binding motif in the N-terminal domain of the protein.215 
Furthermore the contradictory results of SDC2 on TGFβ signaling could provide an 
explanation for the different effects of ANGPTL4, observed in vitro and in vivo. The effect 
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of ANGPTL4 on TGFβ signaling via syndecans could be tissue specific or dependent on 
the respective microenvironment.      
Syndecans also function in Wnt signaling. SDC1, for example, was described as a 
modulator of Wnt signaling and is required for WNT1 induced mammary tumorigenesis 
in mice.266 Furthermore SDC4 was shown to act as a co-receptor for RSPO3 in Wnt/PCP 
signaling in Xenopus, and mediates clathrin-dependent internalization of RSPO3.52,78 
Additionally, it has been shown that besides noncanonical Wnt signaling, SDC4 also has 
an effect on canonical Wnt signaling, as it inhibits Wnt/β-catenin signaling in mammalian 
cell lines and Xenopus.267 Therefore the observed effect of ANGPTL4 on Wnt/β-catenin 
signaling could be mediated by syndecans. This is further supported by the observation 
that SDC1 synergizes with ANGPTL4 in Wnt/β-catenin inhibition. These results indicate 
that ANGPTL4 and syndecans cooperate in Wnt signal inhibition.  
In contrast to the observed effect of ANGPTL4 on mesoderm development, SDC4 
however, has no effect on Xbra expression.78 This could be due to redundant effects of 
other SDC members, which could mediate the effect of ANGPTL4 during mesoderm 
formation. It is also possible that other receptors transmit ANGPTL4 signals in this 
process. A close examination of ANGPTL4 and syndecans reveals a number of 
overlapping functions during development. Similar to ANGPTL4 knockout mice, SDC1, 
SDC3 or SDC4 deficient mice are viable, fertile and have no overt phenotypic 
abnormalities.228,266,284-286 On the molecular level, however, ANGPTL4 and syndecans are 
implicated in several overlapping biological mechanisms in vertebrates. For SDC1 
deficient mice a very slow re-epithelization during wound healing was described, similar 
to ANGPTL4 knockout mice.234,287 Furthermore SDC1 plays an important role in 
regulating inflammation, similar to ANGPTL4.233,288 Both ANGPTL4 and SDC2 are required 
for angiogenesis.245,289 Additionally, SDC4 deficiency results in delayed wound healing 
and defective angiogenesis, a process in which ANGPTL4 is also required.225,234,286 This 
shows that ANGPTL4 and syndecans are involved in the same biological processes, and 
suggests that syndecans may mediate the effects of ANGPTL4.   
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7.3.5 Syndecans mediate the internalization of ANGPTL4 
A characteristic of syndecans is their ability to induce endocytosis upon ligand 
binding.261-264 It was shown that ANGPTL4 is internalized via clathrin-dependent 
endocytosis, which requires syndecans and sulfation of their GAG chains. This is in 
accordance with binding of other extracellular proteins.78,278,279 Similarly, binding of 
RSPO3 to SDC4 also requires GAGs and induces clathrin-mediated endocytosis.78    
Whether the internalization of ANGPTL4 is required for its inhibitory effect on Wnt/β-
catenin signaling is unknown. In the context of Wnt signaling, internalization of the 
receptor complex is an essential step in the initiation of signal transduction.89,106,290 In 
vertebrates, Wnt ligands induce caveolin-dependent receptor endocytosis, whereas 
DKK1 promotes clathrin-dependent endocytosis of LRP5/6, leading to inhibition of the 
pathway.95,106,107 Because ANGPTL4 acts as an inhibitor of Wnt signaling and is 
internalized via clathrin-dependent endocytosis, similar to DKK1, it is feasible that its 
internalization plays an important role with regard to Wnt signaling.  
7.3.6 ANGPTL4 reduces LRP6 at the plasma membrane level 
The similarity of ANGPTL4 internalization to that of DKK1 and RSPO3, and the fact that 
ANGPTL4 and syndecans synergize in Wnt/β-catenin inhibition, raised the possibility that 
ANGPTL4 affects the Wnt receptor complex via syndecans. Indeed, in the presence of 
syndecan, ANGPTL4 interacts with LRP6. Via this interaction ANGPTL4 regulates cell 
surface levels of LRP6, as shown by gain- and loss-of-function studies. It can be 
hypothesized that ANGPTL4 removes LRP5/6 from the cell surface via clathrin-
dependent endocytosis, thereby attenuating Wnt signaling. Interestingly, it was found 
that the N-terminal CCD of ANGPTL4 is sufficient to decrease LRP6 membrane levels, 
whereas the C-terminal FLD is dispensable. As the CCD was already characterized to 
harbor the binding site for HSPG215, it further underlines that syndecans mediate the 
observed effects of ANGPTL4.  
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7.3.7 Model of ANGPTL4 inhibition of Wnt/β-catenin signaling 
Collectively the data shown here support a model, in which ANGPTL4 binds to 
syndecans, which likely mediate the interaction of ANGPTL4 with LRP6. This interaction 
results in the membrane clearance of LRP6, likely by clathrin-mediated endocytosis of 
the receptor complex, which in turn inhibits Wnt/β-catenin signaling (Figure 33). The N-
terminal domain of ANGPTL4 is sufficient to affect LRP6 membrane levels.  
Clathrin-mediated endocytosis targets membrane proteins to early endosomes, where 
they can be either recycled or transported to late endosomes and lysosomes for 
degradation.95 As also total LRP6 levels are affected by ANGPTL4, it is possible that LRP6 
is undergoing lysosomal degradation, after ANGPTL4-induced removal from the plasma 
membrane. Further investigation is required to proof this hypothesis.  
 
 
 
Figure 33| Model for the inhibitory effect of ANGPTL4 on Wnt/β-catenin signaling. ANGPTL4 binds to 
syndecans via its N-terminal coiled-coil domain. This requires sulfation of the glycosaminoglycan chains of 
syndecans. Thereby ANGPTL4 associates with LRP6 and likely induces clathrin-mediated endocytosis of 
this complex. This results in a decrease of LRP6 membrane levels, leading to the inhibition of Wnt/β-
catenin signaling. 
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In general, syndecans do not act as primary receptors but rather as co-receptors.277 
Therefore it is possible that ANGPTL4 interacts with another transmembrane protein, 
which mediates the interaction with the Wnt receptors. This is supported by the fact 
that ANGPTL4 has no effect on FGF signaling, a signaling pathway in which syndecans 
have also been implicated.264,278,279 The identification of this additional factor could 
provide an explanation for the specificity of ANGPTL4 for Wnt/β-catenin and TGFβ 
signaling. 
 
7.3.8 Outlook 
This study led to the identification of a novel antagonist of the Wnt/β-catenin signaling 
pathway. The inhibitory effect of ANGPTL4 is of physiological relevance, as it promotes 
notochord formation during Xenopus development. Because both ANGPTL4 and Wnt 
signaling are implicated in cancer development and progression, it will be very 
interesting to see if the anti-angiogenic function of ANGPTL4 is mediated via inhibition of 
Wnt/β-catenin signaling. In accordance with this hypothesis is the finding that ANGPTL4 
is frequently silenced by methylation in human gastric cancers,244,291 where Wnt 
signaling is aberrantly activated.292 Interestingly, the tumor suppressive effect of 
ANGPTL4 is mediated by the N-terminal CCD,244 which is in line with our results, showing 
that the N-terminal part of ANGPTL4 is sufficient to decrease LRP6 membrane levels.    
The finding that syndecans are (co-)receptors for the orphan ligand ANGPTL4 opens new 
directions for studies of ANGPTL4 functions. Based on the number of overlapping 
biological roles of ANGPTL4 and syndecans and the implication in cancer and tumor 
progression, it will be interesting to analyze the functional interaction in these 
processes. 
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8. Materials and Methods 
8.1 Equipment and reagents 
 
Equipment 
Agarose gel chambers (Biozym), Balances (Sartorius, Kern), Blotting apparatus Trans-Blot 
SD Semi-Dry Transfer Cell (Biorad), Centrifuges (Heraeus), Electroporator (BioRad), 
Fluorescence microscope (Nikon), Homogenizers (Wheaton), Imaging System LAS3000 
(Fujifilm), Incubators (Labotect, Heraeus), Laminar flow hoods (Labotect), LightCycler 
480 (Roche), Light Source KL1500 (Schott), Luminometer (Fluoroskan Ascent FL, 
Thermo), Magnetic stirrer (CAT), Microcentrifuges (Heraeus), Microinjector (Harvard 
Apparatus), Microwave (Sharp), Multiscan RC plate-reader (Labsystems), Multi-channel 
pipettes (Transferpette), PAGE minigel chambers (Biorad), PCR thermocyclers (MJ 
Research, BioRad), pH meter (Sartorius), Power supplies (Biorad), Rotators (CAT, Kisker), 
Shakers (Thermo, EB), Spectrophotometer NanoDrop 2000 (Thermo), Stereomicroscopes 
MZ8 (Leica), Stereomicroscope Discovery.V20 (Zeiss), Thermoshaker (Eppendorf), 
Thermostat cabinet (Aqua Lytic), Ultrapure water purification system (Millipore), UV 
photodocumentation system (Intas), Vortexer (Scientific industries), Water baths 
(Julabo, GFL). 
 
Chemicals 
Acetic Acid (Merck), Acrylamide (Roth), Agarose (Biozym), Ampicillin (Sigma), Biotin 
(Pierce, Thermo), Blocking Reagent (Roche), BM Purple AP substrate (Roche), 
Bromophenol blue (Merck, Serva), BSA Grade V (Roche), β-mercaptoethanol (Roth), 
CaCl2 (Merck), CHAPS (Serva), Chloroform (Roth), complete protease inhibitor cocktail 
(Roche), L-cysteine (Sigma), DMSO (Sigma), dNTPs (Thermo, Fermentas), DTT (Roche, 
Sigma), Diethylpyrocarbonate (DEPC) (Roth), EDTA (Gerbu), EGTA (Sigma), Ethanol 
(Sigma), Ethidium bromide (Roth), Fluoromount-G (SouthernBiotech), Freon (Riedel-de 
Haën), Formaldehyde (J.T. Baker), Formamide (Merck), Formamide deionized 
(AppliChem), Glycogen (Fermentas), Glycerol (Roth, Sigma), Heparin (MP), human 
chorionic gonadotropin (HCG) (Sigma, Aska), HCl (Sigma), Hydrogen peroxide (Merck), 
HEPES (GERBU), Hoechst (Sigma), Iodacetamide (Sigma), Isopropanol (Sigma), KCl (Fluka, 
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Roth, Sigma), LB agar (Fluka), Maleic acid (Serva), Methanol (Sigma), MgCl2 (Merck), 
MgSO4 (Merck), Monodansylcadaverine (MDC) (Sigma), MOPS (Sigma), NaOH (Fluka), 
NaCl (Sigma, VWR), NaF (Sigma), Na2HPO4 (Merck), NaH2PO4 (Roth), Na3VO4 (Sigma), 
NaOAc (Fluka, Merck), Nonidet NP-40 (Sigma), Phenol (Roth), Phenol/Chloroform 
(Ambion), Paraformaldehyde (PFA) (Merck, Sigma), PMSF (Sigma), Proteinase K (Roche), 
Random Primers (Invitrogen), Restore Western Blot Stripping Buffer (Thermo), RNA cap 
structure analog (NEB), RNase-free H2O (Qiagen), Rose-Gal (Genaxxon), Roti-Phenol 
(Phenol/Chloroform/Isoamylalcohol-25/24/1) (Roth), SDS (Roth), Sephadex beads C-25 
(GE Healthcare) and G-50 (Sigma), Sodium pyrophosphate (Sigma), Streptavidin (Vector, 
SA-5000), TEMED (Serva), Trypsin (Sigma), Triton X-100 (Gerbu), Triethanolamine 
(Sigma), Trizol (Ambion), Tris base (Sigma), Trypan blue (VWR), Tween-20 (Gerbu), Yeast 
RNA (Boehringer Mannheim). 
 
Agarose beads 
Anti-Flag M2 affinity gel (Sigma, A2220), CH-IgG rabbit beads (17.6 mg/ml, homemade), 
Heparin-Agarose (Sigma, H6508), Protein A-Agarose (Sigma, P3476), Streptavidin 
Agarose (Thermo, 20359).  
 
Enzymes, reagents and kits for molecular biology 
4-Dinitrophenylphosphate disodium salt hexahydrate (Sigma, N9389), CIAP (Fermentas, 
EF0341), Clarity Western ECL substrate (BioRad, 1705060), DNA Orange loading dye (6x) 
(Thermo, R0631), DTT 0.1 M (Invitrogen, 00147), Dual-Luciferase reporter assay system 
(Promega, E1960), Gene Ruler DNA ladder 1 kb (Thermo, SM1163), Gene Ruler DNA 
ladder 100 bp (Thermo, SM0241), LDS sample buffer NuPage (Life Technologies, 
NP0008), LightCycler 480 Probes master (Roche, 04887301001), MEGAscript in vitro 
transcription kits SP6/T7/T3 (Ambion, AM1330/AM1334/AM1338), Page Ruler 
Prestained Protein Ladder (Thermo, 26616), PCR buffer (10x) (Life Technologies, 
N8080129), Poly-L-Lysin (Sigma, P5899), ProSieve QuadColor Protein Marker 4.6-
300 kDa (Lonza, 00193837), QIAprep Spin Miniprep Kit (Qiagen, 27106), QIAquick Gel 
extraction kit (Qiagen, 28706), QIAquick PCR purification kit (Qiagen, 28104), QuantaBlu 
Fluorogenic Peroxidase substrate (Pierce, 15169), RiboLock RNase Inhibitor (Thermo, 
EO0381), RiboRuler High Range RNA ladder (Thermo, SM1823), RiboRuler Low Range 
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RNA ladder (Thermo, SM1833), RNA guard (Thermo, EO0381), RNA loading dye (2x) 
(Thermo, R0641), RNase A (Thermo, EN0531), RNase-free DNase Set (Qiagen, 79254), 
SEAP reporter gene assay (Roche, 11779842001), Super signal West Pico 
Chemiluminescence substrate (Thermo, 34078), Superscript II Reverse Transcriptase 
(Invitrogen, 18064-014), UPL probes (Roche), TEV protease (Life Technologies, 12575-
015). 
 
Cell culture reagents and cell lines 
DharmaFECT (Dharmacon), DMEM (Lonza), FCS (Gibco), H1299 cells (American Type 
Culture Collection (ATCC), CRL-5803), H1703 cells (ATCC, CRL-5889), Hanks Balanced Salt 
Solution (Hank’s BSS) (Sigma, H6648), HEK293T cells (GenHunter, WAK-Chemie, Q401), 
HepG2 (ATCC, HB-8065), L cells with/out stably transfected with mouse Wnt3a (ATCC, 
CRL-2647/-2648) L-glutamine (Sigma), Opti-MEM (Gibco), Penicillin-Streptomycin 
(Lonza), RPMI (Lonza), Sodium pyruvate (Sigma), Trypsin-EDTA (Gibco), X-treme Gene 9 
DNA transfection reagent (Roche).  
 
Buffers and solutions 
AP substrate solution: 2 M Diethanolamine pH 9.8, 1 mM MgCl2, 2 tablets 4-
Dinitrophenylphosphate disodium salt hexahydrate (Sigma). 
Barth solution (10x): 880 mM NaCl, 10 mM KCl, 24 mM NaHCO3, 8.2 mM MgSO4·7H2O, 
3.3 mM Ca(NO3)2·4H2O, 4.1 mM CaCl2·2H2O, 100 mM HEPES, pH 7.6. 
DEPC-H2O: 0.01% (v/v) DEPC/ddH2O, mixed for 12 h at room temperature and 
autoclaved. 
Bicarbonate buffer: 50 mM NaHCO3 pH 9.6. 
Bleaching solution (for ISH): 5% Formamide, 0.5% SSC (20x), 3% H2O2 (30%) in ddH2O 
(Formamide has to be diluted in H2O before adding H2O2, otherwise an exothermic 
reaction occurs). 
Boehringer Block (10x): 127 g Tris-HCl, 23.6 g Tris Base, 58.44 g NaCl, 50 g Boehringer 
reagent (Boehringer), add ddH2O up to 1 l, adjust pH to 7.5, dissolves when autoclaved 
and store at -20°C. 
dNTP mix: 2 or 5 mM dATP, dCTP, dGTP, dUTP, store at -20 °C. 
Ethanol/NaOAc mix: 100 mM sodium acetate in 100% ethanol. 
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Hybridization buffer (500 ml): 5 g Boehringer Block, 250 ml deionized Formamide, 
125 ml SSC (20x), dissolve for 1 h at 65°C, add 50 ml yeast RNA (10 mg/ml), 1 ml Heparin 
(50 mg/ml), 2.5 ml Tween (20%), 5 ml CHAPS (10%), 5 ml EDTA (0.5 M), DEPC-H2O, store 
at - 20°C. 
IP lysis buffer: 1% Triton X-100, 2 mM β-mercaptoethanol, 1 mM MgCl2, 1x complete 
protease inhibitor cocktail (Roche), 1x TBS, adjust pH to 7.5. 
IP wash buffer 1: 1% Triton X-100, 2 mM β-mercaptoethanol, 1x TBS, adjust pH to 7.5. 
IP wash buffer 2: 0.1% Triton X-100, 2 mM β-mercaptoethanol, 1x TBS, adjust pH to 7.5. 
Lämmli loading buffer (4x): 5 ml solution C for SDS-PAGE, 2 ml glycerol (100%), 2 ml SDS 
(20%), 1 ml β-mercaptoethanol (14 M), 200 µl bromophenol blue (0.5%). 
Lämmli running buffer (10x): 0.25 M Tris, 1.92 M glycerol, 1% SDS, add up to 1 l 
deionized water, pH ~8.3. 
LB (1x): 10 g tryptone, 5 g yeast, 10 g NaCl. 
Maleic acid buffer (MAB): 100 mM maleic acid, 150 mM NaCl, pH 7.5. 
Modified Ringer solution (MR): 0.1 M NaCl, 1.8 mM KCl, 2.0 mM CaCl2, 1.0 mM MgCl2, 
5.0 mM HEPES-NaOH, pH 7.6, autoclaved. 
MEM buffer (10x): 1 M MOPS pH 7.4, 20 mM EGTA, 10 mM MgSO4. 
MS222 (1 l): 1.5 g MS222 (Sigma), 1.4 g NaHCO3, pH 7. 
NP-40 buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM NaF, 1x complete protease 
inhibitor cocktail (Roche), 1% NP-40, 0.1% SDS, 5 mM β-mercaptoethanol, 5 mM 
glycerophosphate.  
PTW buffer: 1x PBS, 0.1% Tween 20. 
Phosphate-buffered saline (PBS, 10x): 1.36 M NaCl, 26.8 mM KCl, 14.7 mM KH2PO4, 
162.9 mM Na2HPO4, adjusted to 1 l with ddH2O, autoclaved. 
Ringer solution: 116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2, 5 mM HEPES pH 7.4. 
Saponin buffer: 0.05% Saponin, 1 mM MgCl2, 2 mM β-mercaptoethanol, 10 mM NaF, 
5 mM glycerophosphate, 0.1 mM PMSF, 1x complete protease inhibitor cocktail (Roche), 
1x TBS. 
SDS-PAGE solutions: Solution B: 1.5 M Tris, 0.4% SDS in 1 l ddH2O pH 8.8; Solution C: 
0.5 M Tris, 0.4% SDS in 1 l ddH2O pH 6.8. 
TBE buffer (10x, for agarose gel-electrophorese): 540 g Tris Base, 275 g Boric Acid, 
200 ml EDTA (0.5 M) pH 8.0, in 5 l ddH2O. 
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TBE buffer (10x, for semidry blotting): 108 g Tris Base, 55 g Boric Acid, 40 ml EDTA (0.5 
M), add up to 1 l ddH2O, adjust pH to 8.3. 
TEV buffer: 150 mM NaCl, 0.1% NP-40, 0.5 mM EDTA, 20 mM Tris pH 8.0. 
Tris-buffered saline (TBS, 20x): 1 M Tris pH 7.4, 3 M NaCl, 54 mM KCl, add up to 1 l 
ddH2O, autoclaved. 
TBS-T (1x): 1x TBS, 0.05% Tween.  
TE buffer: 10 mM Tris-HCl pH 7.4, 1 mM EDTA, autoclaved. 
Transferbuffer (10x): 58.2 g Tris Base, 29.3 g Glycin, 200 ml EDTA (0.5 M) pH 8.0, add up 
to 1 l ddH2O (for 1x add 200 ml Methanol/l). 
 
Antibodies 
Mouse anti-β-catenin (BD, 610154), Mouse anti-FLAG (Sigma, F-3165), Mouse anti-MAPK 
(ERK1+ERK2) (Sigma, M8159), Mouse anti-myc (DSHB, 9E10), Mouse anti-SMAD2/3 (BD, 
610842), Mouse anti-Tubulin (Sigma, T5168), Mouse anti-V5 (Invitrogen, 46-0705), 
Rabbit anti-AP (Zymed, 18-0099), Rabbit anti-HRP (Acris, R1107), Rabbit anti-LRP6 
(T1479) homemade antibody, Rabbit anti-phospho-LRP6 (Sp1490) (Cell Signaling), Rabbit 
anti-phospho-LRP6 (Sp1490) homemade antibody, Rabbit anti-phospho-SMAD2 
(Ser465/467) (Cell Signaling, 138D4), Rabbit anti-phospho-SMAD3 (Ser423/425) (Cell 
Signaling, C25A9), Rabbit anti-Transferrin receptor (Cell Signaling, 13113P), Rat anti-HA 
(Roche, 1867423). 
 
Plasmids 
Human and mouse ANGPTL4 was received from imaGenes (Table 3). 
Table 3| Human and mouse ANGPTL4 cDNA clones obtained from imaGenes. 
Gene Clone ID IMAGE ID vector 
Human ANGPTL4 IRAUp969A0880D 5088323 pOTB7 
Mouse Angptl4 IRAVp968A0472D 5137159 pCMV-SPORT6 
 
Xenopus angptl4 was cloned by Christine Dolde from st.40 X. tropicalis embryos using 
the following primers: ATGAAGCTGTTACTTGCAAGTATAACT (forward primer), 
CACAGTAAGGTCTGTATCAACAGG (reverse primer). The cloned angptl4 was ligated into 
pCS2+ vector (EcoRI, BamHI) and pBluescript KS+ (BamHI, XbaI).  
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Using the human and mouse ANGPTL4 cDNA clones from imaGenes, different constructs 
were cloned for the experiments performed in this thesis (Table 4). 
 
Table 4| ANGPTL4 constructs cloned for this thesis. AP, alkaline phosphatase; NT, N-terminal domain of 
ANGPTL4; CT, C-terminal domain of ANGPTL4; SP, signal peptide for secretion; Prot.Ax2, two times Protein 
A-tag; TEV, cleavage site for protease from Tobacco Etch Virus; Str., Strep-tag; HRP, horseradish 
peroxidase; myc, myc-tag; h, human; m, mouse.  
Construct Insert Vector Cloning Sites 
hANGPTL4-AP Full length hANGPTL4 pCDNA3 EcoRI, BglII 
hANGPTL4-AP (NT) N-terminal part of hANGPTL4 pCDNA3 EcoRI, BglII 
SP-Prot.Ax2-TEV-Str.-HRP-
hANGPTL4 
Full length hANGPTL4 pCS2+ BspEI, XbaI 
SP-Prot.Ax2-TEV-Str.-HRP-
hANGPTL4 (NT) 
N-terminal part of hANGPTL4 pCS2+ BspEI, XbaI 
SP-Prot.Ax2-TEV-Str.-HRP-
hANGPTL4 (CT) 
C-terminal part of hANGPTL4 pCS2+ BspEI, XbaI 
SP-Prot.Ax2-TEV-Str.-HRP-
mAngptl4 
Full length mAngptl4 pCS2+ BspEI, XbaI 
SP-Prot.Ax2-TEV-Str.-HRP-
mAngptl4 (NT) 
N-terminal part of mAngptl4 pCS2+ BspEI, XbaI 
SP-Prot.Ax2-TEV-Str.-HRP-
mAngptl4 (CT) 
C-terminal part of mAngptl4 pCS2+ BspEI, XbaI 
myc-mAngptl4 Full length mAngptl4 pCS2+ BglII, XhoI 
myc-mAngptl4 (NT) N-terminal part of mAngptl4 pCS2+ BglII, XhoI 
myc-mAngptl4 (CT) C-terminal part of mAngptl4 pCS2+ BglII, XhoI 
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8.2 Molecular Biology 
General molecular biology methods, like preparation of XL1-blue competent cells, 
transformation of plasmid DNA, amplification and quantification of DNA and RNA 
samples, PCR amplification and DNA restriction digest were performed as described.293 
For isolation of plasmid DNA from bacteria, isolation of RNA from cells, and gel 
extraction of PCR fragments Kits from Qiagen were used, according to manufacturer’s 
instructions. DNA oligonucleotides were synthesized by Sigma Aldrich. DNA samples 
were sequenced by GATC Biotech. 
 
Bioinformatic tools 
Genomic sequences were obtained from the public databases NCBI (www.ncbi.nih.gov) 
and Ensembl Genome Browser (www.ensembl.org). Sequence searches and 
comparisons were performed with BLAST (www.ncbi.nlm.nih.gov/BLAST). DNA 
restriction and translation maps were analyzed with the service of DKFZ-HUSAR 
(www.genome.dkfz-heidelberg.de/husar). Real time PCR primers and corresponding UPL 
probes were designed using the Universal ProbeLibrary Assay Design Center from Roche 
(www.roche-applied-science.com/) choosing intron spanning assays. For literature 
searches PubMed was used (www.ncbi.nlm.nih.gov/pubmed).   
 
RNA isolation 
RNA from mammalian cells was isolated using the RNeasy Mini Kit (Qiagen), according to 
manufacturer’s instructions. The RNA of Xenopus embryos/explants was isolated with 
Trizol reagent (Ambion). Samples were homogenized in 1 ml Trizol, and 200 μl 
chloroform was added. Samples were vortexed for 30 sec and then centrifuged at 
13.000 rpm for 15 min and 4°C. The upper aqueous phase was transferred to a fresh 
tube, mixed 1:1 with isopropanol and precipitated at -80°C for at least 1 h, or overnight 
in the case of explants. RNA was pelleted by centrifugation at 13.000 rpm for 30 min. 
RNA pellets were washed with 70% ethanol, again centrifuged, briefly dried and 
dissolved in RNase-free H2O. RNA concentration was quantified by measuring the 
absorbance at 260 nm in a spectrophotometer. 
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cDNA synthesis 
cDNA was synthesized from total RNA using SuperScript II reverse transcriptase. Up to 
1 μg of total RNA was mixed with 1 µl random primers (0.5 µg/µl) and 2 μl dNTPs (5 mM) 
in a total volume of 12 μl and heated to 65°C for 5 min. Samples were cooled on ice and 
2 μl First strand buffer (5x), 1 μl DTT (0.1 M) and 1 μl RNase inhibitor were added. 
Samples were mixed and 0.5 μl SuperScript II reverse transcriptase (100 U) was added. 
Reverse transcription was carried out in a PCR-cycler at 25°C for 5 min, and 42°C for 
90 min. The reaction was stopped by heat-inactivation at 70°C for 15 min. The cDNA 
samples were diluted 1:5 with RNase-free H2O and used for quantification of gene 
expression by qPCR. 
 
Quantitative RT-PCR (qPCR) 
Quantitative real-time PCR was used to examine and compare gene expression levels 
using cDNA templates. The measurements were performed with the Roche 
Lightcycler 480, using UPL mono-color hydrolysis probes. Primer sequences and UPL 
probes, which were used in this thesis are indicated in Table 5. 
For qPCR 11 μl reactions were used, containing 5.5 μl PROBES master (2x) (Roche), 0.5 µl 
primer and probes mix (11 µM of each primer, 2.2 µM UPL probe), and 5 μl cDNA 
template. For the detection of mono-color hydrolysis probes, a program, consisting of a 
pre-incubation step, 55 amplification cycles, and a cooling step, was used. The annealing 
temperature during the amplification cycles was set to 60°C (1 sec hold). All samples 
were analyzed in duplicates. Relative expression levels for marker gene analysis were 
obtained by normalizing the expression to the housekeeping gene odc (Xenopus) or 
GAPDH (human). For each gene a standard curve was generated by usage of a dilution 
series of the respective cDNA. 
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Table 5| Primer and UPL-probes used for qPCR analysis of Xenopus and human genes. Primers were 
ordered from Sigma and UPL probes from Roche.  
Target Primer sequences UPL probe 
Xenopus ANGPTL4 forward: TCTGATTTTAACTGCGCCAAA 
reverse: ATGGCCGCATGAGCTAAA 
UPL probe #88 
Xenopus brachyury forward: TTCAAGGAGCTCACCAATGA 
reverse: CGACACGCTCACCTTTAGAA 
UPL probe #97 
Xenopus chordin forward: AGGAGCCCCTCCAATCTAAG 
reverse: GATGCCATGAATCCTCCAGA 
UPL probe #31 
Xenopus gsc forward: GAAACCAAGTACCCAGACGTG 
reverse: CCTCCACTTTGCTCTTCGAT 
UPL probe #126 
Xenopus myf5 forward: AGCTGCTCAGATGGCATGA 
reverse: AGCTGCTGTTCCTTCCAGAC 
UPL probe #66 
Xenopus myoD forward: GGTCCAACTGCTCCGATG 
reverse: CTGCTGTCGTAGCTGTTCCTT 
UPL probe #1 
Xenopus noggin forward: TGGGGAGTTGGATCTCCTT 
reverse: TTTGATTTCTGCTGGCATTG 
UPL probe #29 
Xenopus odc forward: TTTGGTGCCACCCTTAAAAC 
reverse: CCACTGCCAACATGGAAAC 
UPL probe #50 
Xenopus siamois forward: TTGACCCCCTAGTCAACAGC 
reverse: ACCAGCGGCCTCTTACATT 
UPL probe #101 
Xenopus Xnot2 forward: ACAACAGCAGCCAATGAGG 
reverse: GGCAATGGGAGTAGGGTAAAC 
UPL probe #96 
Xenopus Xnr3 forward: CCAAAGCTTCATCGCTAAAAG 
reverse: AAAAGAAGGGAGGCAAATACG 
UPL probe #102 
Human ANGPTL4 forward: GTTGACCCGGCTCACAAT 
reverse: TGGCGCCTCTGAATTACTG 
UPL probe #75 
Human AXIN2 forward: CCACACCCTTCTCCAATCC 
reverse: TGCCAGTTTCTTTGGCTCTT 
 
UPL probe #36 
Human GAPDH forward: GCATCCTGGGCTACACTGAG 
reverse: AGGTGGAGGAGTGGGTGTC 
UPL probe #82 
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8.3 Cell culture and transfection 
 
Cell lines and culture condition 
HEK293T and HepG2 cell lines were maintained in DMEM, 10% FCS, 
1% penicillin/streptomycin (10.000 U/ml), and 1% L-glutamine (200 mM) at 37°C in a 
humidified atmosphere with 10% CO2. H1703 and H1299 cell lines were grown in RPMI, 
10% FCS, 1% penicillin/streptomycin (50 µg/ml), 1% L-glutamine (200 mM) and 
1% sodium pyruvate (11 mg/ml) at 37°C in a humidified atmosphere with 5% CO2.  
 
Preparation of the WNT3A conditioned medium 
WNT3A conditioned medium was produced from mouse L-cells stably transfected with 
mouse WNT3A (ATCC, CRL-2647) and the control conditioned medium was received 
from non-transfected L-cells (ATCC, CRL-2648).294 To obtain conditioned medium, cells 
were split 1:10 and grown for two to three days until confluence. Cells were 
supplemented with fresh medium and 2 days later conditioned medium was harvested. 
The medium was centrifuged at 2500 rpm for 5 min at 4°C, to remove residual cells, and 
stored in glass bottles at 4°C.  
 
Preparation of ANGPTL4, R-spondin and DKK conditioned medium 
HEK293T cells were seeded in 15 cm-dishes one day before transfection that they 
reached 80% confluence at the following day. For transfection 10 µg of the respective 
Plasmid-DNA was used. The cells were transfected using X-treme Gene9 (Roche) 
transfection reagent according to manufacturer’s instructions. On day after transfection 
medium was changed and after 48 h - 72 h medium was harvested. The conditioned 
medium was centrifuged at 2500 rpm for 5 min and 4°C. The medium was stored in glass 
bottles at 4°C. In total 3 harvests of conditioned medium were collected.  
  
Transfection of DNA 
For DNA transfection, cells were seeded one day before. Transfection of DNA was 
carried out using X-treme Gene9 (Roche) according to the manufacture’s instruction. 
The cells were harvested for analysis after one to three days. 
For cell surface binding assays, HEK293T cells were seeded one day before transfection 
on Poly-L-Lysine-treated 24-well plates, that they reached 50% confluence at the day of 
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transfection. For immunofluorescence, cells were seeded one day before transfection on 
glass coverslips in 24-well plates. On day of transfection cells reached 60-70% 
confluence.  
 
Transfection of siRNA 
Cells were transfected with siRNA using Dharmafect (Dharmacon) transfection reagent 
according to manufacturers’ instruction. In general, cells were cultured for two to three 
days for RNAi effect to occur. 
 
Luciferase reporter assay  
Luciferase assays were carried out in 96-well plates in triplicates. Cells were transfected 
with different constructs, including Firefly (TOPFlash reporter plasmid, which contains 
TCF/LEF binding sites in the promoter driving the expression of a Firefly luciferase 
construct) and Renilla luciferases. For the transfection of one 96-well the following DNA 
concentrations were used: 10 ng TOPFlash, 5 ng pTK-Renilla, 10 ng mWnt1, 2 ng mFzd8, 
12 ng hLRP6, 0.2 ng Xenopus β-catenin, 40 ng hDVL. pCS2+ DNA was used to adjust total 
DNA amount to 100 ng per well of a 96-well plate.  
For monitoring TGFβ, BMP and FGF signaling different luciferase reporters were used 
(Table 6). 
Table 6| Luciferase reporter constructs used to monitor TGFβ, BMP and FGF signaling. 
Signaling pathway Luciferase reporter 
construct 
Concentration 
per well 
Reference 
TGFβ/SMAD2 signaling ARE-luc reporter, FAST1 10 ng, 1 ng 295 
BMP/SMAD1 signaling BREx4-luc reporter 10 ng 296 
FGF signaling Gal-Elk/Gal-luc 2 ng / 10 ng 297,298 
 
After 24 to 48 hours of transfection, cells were lysed in 50 μl passive lysis buffer (1x, 
Promega) for 15 min at RT with continuous shaking. 15 µl of the lysates was transferred 
to 96-well white Microtiter Plates (Thermo Electron Corporation). The dual Luciferase 
Assay Kit (Promega) was used to measure Firefly and Renilla luciferase activities using a 
Fluoroskan Ascent FL luminometer (Labsystems) according to manufacturer’s 
instruction. The activity of Firefly luciferase was normalized to Renilla luciferase activity.  
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8.4 Xenopus methods 
In vitro fertilization, culturing of embryos, staging and microinjection of X. laevis and 
X. tropicalis embryos were generally carried out as described.299-302 Morpholinos were 
ordered from Gene Tools. 
 
Priming, fertilization and microinjection  
X. laevis females were injected with 600 U of human chorionic gonadotropin (HCG, 
Sigma, Aska) to induce ovulation. X. tropicalis females were pre-primed with 10 U of 
HCG in the evening before the experiment. On the next morning, females were injected 
with 200 U of HCG. About 4 h later females started laying eggs, which were in vitro 
fertilized by mixing them with a piece of testis minced in 1x Ringer’s solution. After 
3 min, eggs were covered with 0.1x Barth solution to promote sperm activation. After 
20-25 min, embryos were de-jellied in 2% cysteine in ddH2O, pH 7.6. Embryos were 
washed three times in 0.1x Barth solution followed by 2 washes and cultivation in 1/9x 
Modified Ringer. Microinjections were performed in 1% agarose (dissolved in 1/9x 
Modified Ringer) dishes containing 1/9x Modified Ringer and 2% Ficoll 400, using 
calibrated glass capillary needles. Embryos were injected at 1- to 8-cell stage with a total 
volume of 5 to 10 nl per embryo. After injection embryos were cultured in 1/18x 
Modified Ringer in plastic dishes at temperatures between 18°C and 25°C. 
 
Morpholino injections  
Morpholinos were designed according to the general guidelines suggested by Gene 
Tools, LLC. All obtained Mos were dissolved in RNase-free H2O to a final concentration of 
20 µg/µl and stored at RT. Mos, which were used in this thesis are indicated in Table 7. 
Before injection, Mos were heated up to 70°C for 3 min, chilled on ice for 5 min and then 
kept at RT during injection.  
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Table 7| Morpholinos with their respective sequences used in this thesis. Morpholinos were ordered 
from Gene Tools and concentration was adjusted to 10 µg/µl in RNase-free H2O. 
Gene Morpholino sequence Target site Reference 
LGR4 Mo1 CAACAGCTTGCACGGTCCGACACCT 5'UTR 169 
LGR4 Mo2 CACAACCTGCACTTTATTTGGCCGC 5'UTR 169 
LGR4 Mo3 GCCATACTTACAGCGAGTGGGTGAA splice site 169 
LGR5 Mo1 AGGTGTCCATGGTGCCGATCAGATC ATG 169 
LGR5 Mo2 CGCTGCTCTAATGGTGCAGGCTAAA 5'UTR 169 
LGR5 Mo3 GCTTGAAAGGTCCTAGGGAGAAAAG splice site 169 
RSPO3 Mo ATGCAATTGCGACTGCTTTCTCTGT ATG 86 
RAB8B Mo1 GGTAGTCGTAAGTCTTCGCCATCTT ATG 197 
RAB8B Mo2 AAGTCTTCGCCATCTTTAGTCCTCC ATG 197 
LRP6 Mo CCCCGGCTTCTCCGCTCCGACCCCT 5’UTR 303 
ANGPTL4 Mo1 TTTATCTGACCTGAAAGGTGTTTGG splice site - 
ANGPTL4 Mo2 TGTCGGCCACTCACTTGAAACAATA splice site - 
 
 
Explants 
Explants were generally performed as described.304 In brief, excision of explants was 
performed in dishes covered with a layer of 1% agarose (dissolved in 0.5x Barth) and 
0.5x Barth solution. The vitelline membrane of embryos was removed and explants were 
cut using two watchman forceps (Dumont number 5). Explants were cultured in agarose-
coated dishes in 0.5x Barth until the desired stage. 
 
Luciferase reporter assay in Xenopus embryos 
For Wnt reporter assays in Xenopus embryos 80 pg TOPFlash DNA, containing three 
copies of the TCF-binding site, together with 25 pg pRLTK (Renilla) DNA for 
normalization, was injected into Xenopus embryos together with Mos and mRNAs. At 
the desired stage, embryos were collected and lysed in 1x passive lysis buffer (6.7 µl lysis 
buffer/embryo for X. tropicalis and 15 µl lysis buffer/embryo for X. laevis). Lysates were 
vortexed 10 min and centrifuged at 13.000 rpm for 10 min at 4°C to remove yolk. Firefly 
and Renilla luciferase reporter activity was measured in triplicates using the dual 
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luciferase assay system (Promega) and a Fluoroskan Ascent FL luminometer 
(Labsystems). The activity of Firefly luciferase was normalized to Renilla luciferase 
activity. 
 
Preparation of mRNA for embryo injections  
For mRNA synthesis linearized DNA template was used. The synthesis was performed 
using the MEGAscript in vitro transcription kits from Ambion. RNA cap structure analog 
was added to increase stability and translation efficiency of the mRNA. Since free cap 
analog is a potent translation inhibitor and toxic to cells, mRNA was purified after 
synthesis.  
 
Linearization of DNA template  
Plasmid DNA (5 µg) was linearized by restriction digest for 2 h at 37°C. After linearization 
the DNA was purified by phenol-chloroform extraction. The upper phase (100 µl) was 
precipitated with 200 µl ethanol (100%), 10 µl NaOAc (3 M) and 2 µl glycogen (4 mg/ml) 
at -80°C for at least 1 h. Precipitate was pelleted at 13.000 rpm for 20 min, washed with 
70% ethanol, dried and resuspended in 10 µl ddH2O. 
 
Synthesis of mRNA 
For mRNA synthesis 1 µg of linearized DNA was used for a 20 µl reaction: 
2 µl  10x buffer (Ambion MEGAscript kit)   
2 µl  ATP solution (75 mM for T3/T7, 50 mM for SP6)   
 2 µl   CTP solution (75 mM for T3/T7, 50 mM for SP6) 
  2 µl   UTP solution (75 mM for T3/T7, 50 mM for SP6) 
 0.4 µl   GTP solution (75 mM for T3/T7, 50 mM for SP6) 
 3.75 µl  RNA cap structure analog (40 mM) 
 2 µl  T7 / T3 / SP6 RNA polymerase (Ambion MEGAscript kit) 
 2 µl  DNA template (1 µg) 
 3.85 µl  RNase-free H2O (Qiagen)      
 20 µl 
 
Samples were incubated at 37°C for 2 h, and subsequently treated with 1 μl DNase I 
(RNase free, Roche) at 37°C for 15 min. After the synthesis 10 volume-% of EDTA (0.5 M) 
was added. 
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Purification of RNA transcript  
For the purification of the synthesized mRNA self-made columns were used. Tips (200 µl) 
were filled with glass wool, and 300 µl G50-sephadex beads and 100 µl C25-sephadex 
beads in G+E buffer were added. Columns were washed two times with 300 µl G+E 
buffer at 1500 rpm and 4°C. The mRNA was applied to the columns and centrifuged for 
2 min at 1500 rpm and 4°C. Concentration was determined photometrically and quality 
of the mRNA was analyzed on an agarose gel.  
 
DIG-labeled RNA probes for in situ hybridization 
Synthesis of DIG-labeled RNA probes was performed using linearized template DNA, RNA 
polymerase from the in vitro transcription kit from Ambion (Ambion MEGAscript Kit), 
and DIG-labeled dNTPs. Linearization of Plasmid-DNA and purification was conducted as 
described before for mRNA synthesis.  
For a 20 µl reaction volume 1 µg of linearized template DNA was mixed with the 
following components: 
2 µl  10x buffer (Ambion MEGAscript kit)  
4 µl   DIG-labeled dNTPs (Roche) 
2 µl  T7 / T3 / SP6 RNA polymerase (Ambion MEGAscript kit) 
3 µl  DNA template (1 µg) 
             9 µl  RNase-free H2O (Qiagen)      
          20 µl 
 
DIG-labeled RNA probes were synthesized for 2 h at 37°C. After addition of 1 µl DNase I 
(Ambion MEGAscript kit) for 15 min at 37°C the reaction was stopped by adding 10 
volume-% of EDTA (0.5 M). The purification was performed as described for the mRNA 
transcript but only G50-sephadex beads were used. The concentration was determined 
photometrically and quality of the DIG-labeled RNA probe was analyzed on an agarose 
gel.   
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Lineage tracing in Xenopus embryos 
For lineage tracing experiments in Xenopus embryos, lacZ mRNA (200 pg per half of the 
embryo) was unilaterally co-injected and β-galactosidase staining was performed as 
described,302 using Rose-Gal substrate. After staining of the embryos the protocol for in 
situ hybridization was followed. 
 
Whole mount in situ hybridization (WMISH) 
WMISH of Xenopus embryos was carried out as described in the following.  
Preparation of embryos (Day 0) 
Embryos are collected at the desired stage in 5 ml glass vials and fixed in freshly 
prepared MEMFA (1x MEM, 3.7% formaldehyde, in DEPC-H2O) at RT, for 1 h. After 
fixation embryos were dehydrated using different dilutions of methanol in DEPC-H2O 
(25%, 50%, 75% and four times 100%) for 5 min, each on a roller. Dehydrated embryos 
were stored in 100% methanol at -20°C until hybridization. 
Hybridization (Day 1) 
Washes and incubations were preformed in 3 ml for 5 min, if not stated otherwise. Fixed 
embryos were rehydrated through a reverse series of methanol in DEPC-H2O (100%, 
75%, 50%, 25%), and then washed four times with PTW buffer. Embryos were treated 
with proteinase K (10 µg/ml in PTW) to increase the permeability of the tissue for 
hybridization probes and antibodies. Embryos of all stages were treated with proteinase 
K for 7 min. Vials were not shaken or rolled during the incubation. To stop the 
proteinase K digest, embryos were washed three times with PTW, followed by two 
washes in 0.1 M triethanolamine. To neutralize positive charges, which would otherwise 
bind nucleic acids by ionic bonding, resulting in high background staining, acetic 
anhydride treatment was included. Embryos were incubated in 3 ml triethanolamine 
with 7.5 µl acetic anhydride for 5 min on a roller. Additional 7.5 µl of acetic anhydride 
was added and embryos were rolled again for 5 min. Embryos were washed three times 
in PTW for 5 min. Embryos were re-fixed for 20 min in freshly prepared 4% 
formaldehyde in PTW. Embryos were rinsed five times in PTW. For pre-hybridization, all 
but 1 ml of PTW was removed and 250 µl hybridization buffer was added. After embryos 
have settled, the buffer was replaced by 500 µl hybridization buffer. Again embryos 
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were allowed to settle, before hybridization mix was replaced. Embryos were incubated 
in hybridization buffer for 30 min at 65°C with gentle shaking in a water bath. 
Hybridization buffer was replaced and embryos were pre-hybridized for 6 h with gentle 
shaking in a water bath. At this point, embryos were either processed directly or stored 
at -20°C. 
Pre-hybridized embryos were incubated at 65°C in a water bath for at least 10 min. DIG-
labeled RNA probes were diluted in hybridization buffer to a concentration of 200-
750 ng/ml for angptl4, myf5, muscle actin, collagen and chordin. The RNA probes were 
denatured by heating up for 3 min at 95°C. Then probes were immediately cooled down 
on ice for 5 min and afterwards heated to 70°C for 10 min. The hybridization buffer of 
the embryos was replaced by 500 µl of the respective probe. Hybridization was carried 
out over night at 60°C in a water bath with gentle rocking. Probe dilutions were 
recovered and re-used, resulting in less background after several rounds of 
hybridization. 
Solutions for washing steps were pre-warmed at 65°C. RNA probes were replaced by 
500 µl hybridization buffer and after 10 min, 500 µl of 2x SSC was added to the embryos 
and incubated for 20 min. Embryos were washed three times 20 min in 2x SSC. Embryos 
were treated with 10 µg/ml RNase A for 30 min at 37°C. RNase was removed by washing 
of the embryos with 2x SSC for 10 min at RT, followed by two washes for 30 min in 0.2x 
SSC at 65°C. Embryos were incubated in freshly prepared MAB on a roller for two times 
15 min at RT. Embryos were washed for 15 min in 2% Boehringer Block reagent in MAB, 
followed by blocking for 1 h in 2% Boehringer Block reagent and 10% goat serum in MAB 
rolling at RT. The blocking solution was replaced by a 1:5.000 dilution of anti-
Digoxygenin-AP Fab fragments (Roche) in 2% Boehringer Blocking reagent and 10% goat 
serum in MAB. After 4 h with gentle rocking at RT, embryos were washed 2x with MAB 
for 30 min. The washing was continued over night at 4°C on a roller. On the following 
day embryos were again washed eight times 10 min at RT, following two times 5 min in 
water. 
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Color reaction 
Water was replaced with BM Purple AP substrate (Boehringer Mannheim) and staining 
was proceeded in the dark with gentle shaking. Staining was analyzed regularly. If 
staining had to be proceeded for several days, the staining solution was replaced every 
morning and evening and incubation occurred at 4°C at night. After staining reached the 
desired intensity, embryos were washed once in water for 5 min, followed by 100% 
methanol for 2-3 min and 50% methanol for 5 min, to remove unspecific background 
staining. Methanol was removed by washing again with water and embryos were stored 
in 1x MEMFA.  
 
Bleaching of Xenopus embryos 
Xenopus embryos were bleached to remove the natural pigmentation, as this might 
mask the hybridization signals. Embryos, stored in MEMFA, were washed once in 1x SSC 
for 5-10 min at RT. The washing solution was replaced by bleaching solution and the 
glass vials were rolled in the cold room (4°C) under direct light. The incubation at 4°C 
prevents the embryos from turning black during the exothermic reaction. Embryos were 
incubated until pigmentation was removed (approximately 1-2 h). Embryos were rinsed 
two times with PBS and fixed and stored in 1x MEMFA until pictures were taken. 
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8.5 Biochemical methods 
 
Membrane and cytosolic cell extraction  
The Western blots for LPR6 and β-catenin were performed using membrane and 
cytosolic extracts, respectively. Medium of cells was removed and 1 ml ice cold Hank’s 
BSS was added. Cells were scraped from plate and centrifuged at 1500 rpm and 4°C for 
5 min. Cell pellets were stored at -80°C until extraction was performed.  
The cell pellets were resuspended in 50-100 µl Saponin buffer, and incubated on ice for 
30 min. After centrifugation at 13.500 rpm and 4°C for 5 min, supernatant containing the 
cytosolic fraction was mixed with Lämmli loading buffer, boiled at 95°C for 3 min and 
stored at -20°C until Western blot analysis. 
The pellet, containing the membrane fraction, was resuspended in 50 µl NP-40 Lysis 
buffer and after 30 min incubation on ice, samples were centrifuged at 10.500 rpm and 
4°C for 3 min. The supernatant was mixed with LDS sample buffer (4x) and 10 mM DTT, 
heated up to 70°C for 10 min and samples were stored at -20°C until Western blot 
analysis.  
 
SDS-PAGE and Western blot 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were 
performed according to standard protocols.293 The signals were detected with the 
SuperSignal® West Pico Chemiluminescent substrate (Pierce) or for weak signals with 
the Clarity Western ECL substrate (BioRad). Chemiluminescene was detected with the 
luminescent image analyzer LAS3000 (Fujifilm). 
 
AP activity assay 
For the AP-tagged constructs, produced as conditioned medium, the AP activity was 
determined. As a reference for the AP activity, a dilution series of calf intestine alkaline 
phosphatase (CIAP, 1000 U/ml) (Fermentas) was prepared in DMEM. The measurement 
was performed at 405 nm in 96-well plates using 50 µl AP substrate solution per well. 
After addition of 1 µl conditioned medium or different dilutions of CIAP, the absorption 
at 405 nm was measured. The CIAP standard curve was used to determine the AP 
activity of the different AP-tagged constructs. 
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HRP activity assay 
The HRP activity of the HRP-tagged constructs, produced as conditioned medium, was 
measured using the QuantaBlu Fluorogenic peroxidase substrate kit (Pierce). The 
measurement was performed according to manufacturer’s instructions. For one well of a 
96-well plate 100 µl substrate solution (9x QuantaBlu substrate solution, 1x QuantaBlu 
stable peroxide solution) was mixed with 1 µl of the conditioned medium containing the 
HRP-tagged protein.       
 
Tyramide signal amplification of HRP-tagged proteins 
HepG2 cells, seeded on glass cover slips, were incubated for 40 min with conditioned 
medium containing 50 U/µl of the respective HRP-tagged protein. Afterwards cells were 
washed three times with ice cold Hank’s BSS and fixed with 0.5 mM DSP in Hank’s BSS 
with 10 mM HEPES pH 7.2 for 15 min on ice and additional 30 min at RT. Fixation 
solution was removed and cells were permeabilized with 0.1% saponin in TSA buffer 
(100 mM Tris, 10 mM imidazole pH 8.8) for 15 min at RT. The TSA reaction was 
performed for 30 min in the dark in a humidified chamber using 3 µM Rhodamine- 
tyramide and 0.003% H2O2 in TSA buffer. After staining of the HRP-tagged proteins, cells 
were washed three times 10 min at RT with PBS containing 0.1% saponin. In the second 
wash step a 1:10.000 dilution of Hoechst was added to stain nuclear DNA of the cells. 
Cover slips were briefly rinsed with ddH2O before mounted with the Fluoromount-G 
(SouthernBiotech) on a glass slide (Roth).    
The treatment of cells with different endocytic inhibitors and siClathrin or siCaveolin was 
performed as described previously.169 
 
Cell surface binding assay 
For cell surface binding assays, HEK293T cells were seeded on Poly-L-Lysin treated 
plates. For this purpose Poly-L-Lysin was diluted 1:20 in ddH2O and 1 ml was added to 
each well of a 24-well plate for 1 h at RT. Afterwards plates were washed three times 
with ddH2O and UV-treated for 30 min. Plates were directly used for seeding of cells or 
stored at RT up to 6 months. One day after seeding, cells were transfected with DNA 
(200 ng/well) using X-treme Gene 9 (Roche), according to manufacturer’s instructions. 
The AP-tagged proteins were produced as conditioned medium as described in 8.2 Cell 
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culture methods, preparation of ANGPTL4 conditioned medium. Cell surface binding 
assay was performed like described before.78  
 
ELISA based binding assay 
For the ELISA-based binding assay, white 96-well plates with high binding affinity 
(Greiner) were used. Plates were coated with 2 µg/ml streptavidin in bicarbonate buffer 
over night at 4°C. On following day, plate was washed three times with TBS-T and 
blocked with 5% BSA in TBS-T for 1 h at RT. After four additional washing steps with TBS-
T, Strep-tagged ANGPTL4 / RSPO3 / DKK3 conditioned medium was added in 5% BSA in 
TBS-T. Binding was performed over night at 4°C and plate was washed three times with 
150 µl and four times with 300 µl TBS-T on next day. Soluble AP-tagged SDC4 was added 
in different dilutions in 5% BSA in TBS-T and 1 mM MgCl2 for 2 h at RT with gentle 
shaking. Unbound SDC4 was removed by washing three times with 150 µl and four times 
with 300 µl TBS-T. For the detection of bound AP-tagged SDC4, the SEAP reporter gene 
assay kit (Roche) was used. For each well 50 µl substrate solution (50 µl SCPD, 950 µl 
substrate buffer) was added, incubated for 10 min and chemiluminescence was 
measured.  
 
Co-immunoprecipitation for identification of ANGPTL4 interaction partners 
HepG2 cells were seeded in 10x 15 cm-dishes and medium was changed after 24 h. Two 
days after seeding of cells, 15 ml of SP-Prot.Ax2-TEV-Str.-HRP-hANGPTL4 conditioned 
medium (50 U/µl) was added to the cells. After 30 min at 37°C, medium was removed 
and cells were washed three times on ice with ice cold Hank’s BSS. Cells were lysed in 
5 ml ice cold IP lysis buffer for 10 min on ice. Cell lysis was increased using a dounce 
homogenizer. Non-disrupted cells were removed by centrifugation at 13.000 rpm and 
4°C for 3 min. The supernatant was supplemented with 1 mM EDTA and EGTA to avoid 
precipitation of the proteins.  
 
1st purification step using IgG beads 
After a pre-clearing step using sephadex beads, lysates were incubated with 100 µl IgG 
beads over night with rotation at 4°C. On the following day, beads were washed three 
times with IP wash buffer 1 on ice, followed by three washes using 1x TBS and 1% Triton-
X100. To inhibit proteases, beads were washed two times with a buffer containing 1x 
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TBS, 1% Triton-X100, 1 mM PMSF, 0.5 mM EDTA, 1x Benzamidine and 2 mM 
iodacetamide (freshly prepared). After washing once again with 1x TBS and 1% Triton-
X100, beads were washed four times with TEV buffer at 4°C with rotation. To elute 
bound ANGPTL4 protein from the beads, 150 µl of TEV buffer, 1 mM β-mercaptoethanol 
and 3 µl TEV enzyme was added to the beads. Elution was performed over night at 4°C 
with rotation. 
 
2nd purification step using Streptavidin beads 
After centrifugation, new TEV buffer and 2 µl TEV enzyme was added to the beads and 
re-elution was performed 4 times. The different elutions were combined and mixed with 
20 µl Streptavidin beads (Thermo). Binding to beads was proceeded over night at 4°C 
with rotation. The next day, beads were washed three times in IP wash buffer 2. The 
elution of the protein was accomplished by addition of 2 mM Biotin in IP wash buffer 2. 
Four elutions à 30 µl were obtained and analyzed via Western blot. The first two elutions 
were combined and processed for mass spectrometric analysis by the core facility for 
mass spectrometry and proteomics at the “Zentrum für Molekulare Biologie der 
Universität Heidelberg” (ZMBH). 
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9. Abbreviations 
ANG Angiopoietin 
ANGPTL Angiopoietin-like 
AP Alkaline phosphatase 
A-P Anterior-posterior 
AP-2 Assembly protein 2 
APC Adenomatous polyposis coli  
ATF2 Activating transcription factor 2 
ATP Adenosine triphosphate 
BMP Bone morphogenetic protein 
Bp Base pairs 
BSA Bovine serum albumin 
cANGPTL4 C-terminal domain of ANGPTL4 
cDNA Complementary DNA 
CCD Coiled-coil domain 
CCV Clathrin-coated vesicle 
CE Convergent extension  
CK1 Casein kinase 1 
Co Control 
co-IP Co-Immunoprecipitation 
CRD Cysteine-rich domain  
Cys Cysteine 
DEPC Diethylpyrocarbonate 
Dgo Diego 
DKK Dickkopf 
DMEM Dulbecco’s modified Eagle’s medium 
DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP Deoxynucleotide triphosphate 
DTT Dithiothreitol 
D-V Dorsal-ventral 
DVL Dishevelled 
ECD Extracellular domain  
ECM Extracellular matrix 
EDTA Ethylene diamine tetraacetate 
EGTA Ethylene glycol tetraacetate 
ELISA Enzyme-linked immunosorbent assay 
FACS Fluorescence-activated cell sorting 
FCS Fetal calf serum 
FGF Fibroblast growth factor 
flANGPTL4 Full length ANGPTL4 
FLD Fibrinogen-like domain 
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Fmi Flamingo 
FZD Frizzled 
GAG Glycosaminoglycan 
GEF Guanine exchange factor 
GPCR G protein-coupled receptor 
gsc Goosecoid 
GSK3 Glycogen synthase kinase 3 
GTP Guanosine triphosphate 
h Hours 
H1299 Human non-small cell lung carcinoma cell line 
H1703 Human non-small cell lung carcinoma cell line 
HA Hemagglutinin 
HCG Human chorionic gonadotropin 
HEK293T Human embryonic kidney cell 293 with SV-40 large T-antigen 
HepG2 Human hepatocellular liver carcinoma cell line 
HRP Horseradish peroxidase 
HS Heparan sulfate 
HSPG Heparan sulfate proteoglycans 
IP Immunoprecipitation 
ISH In situ hybridization 
JNK Jun-N-terminal kinase  
kDa Kilodaltons 
LDL Low density lipoprotein 
LEF Lymphoid enhancer factor 
LGR Leucine-rich repeat-containing G protein-coupled receptor  
LILRB2 Leukocyte immunoglobulin-like receptor, subfamily B, member 2 
LPL Lipoprotein lipase 
LRP Low-density lipoprotein receptor-related protein 
LRR Leucine-rich repeat 
min Minutes 
Mo Morpholino 
mRNA Messenger RNA 
MVB Multivesicular body 
myf5 Myogenic factor 5 
myoD Myogenic differentiation 1 
nANGPTL4 N-terminal domain of ANGPTL4 
PAGE Poly acrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCP Planar cell polarity 
PCR Polymerase chain reaction 
Pk Prickle 
PPAR Peroxisome proliferator-activated receptor 
Pro Proline 
PRR Prorenin receptor 
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qPCR Quantitative PCR 
RNA Ribonucleic Acid 
RNAi RNA interference  
RNF43 Ring finger protein 43 
rpm Revolutions per minute 
RSPO R(oof plate-specific)-spondin 
RT Room temperature 
RT-PCR Real-time polymerase chain reaction 
SD Standard deviation 
SDC Syndecan 
SDS Sodium dodecylsulfate 
Sec Seconds 
Ser Serine 
siRNA Small interfering RNA 
St Stage 
Stbm Strabismus 
TAG Triacylglycerols 
TCF T-cell factor 
TEMED Tetramethyl ethylene diamine 
TGF Transforming growth factor  
Thr Threonine 
UPL Universal probe library 
wt Wildtype 
Xbra Xenopus brachyury 
Xnot Xenopus notochord  
Xnr Xenopus nodal related protein 
ZNRF3 E3 ubiquitin ligase zinc and ring finger 3 
 
 
For simplicity the human nomenclature was used for all genes and proteins within this 
thesis. Appropriate nomenclature is indicated below with LGR as an example. 
Species Gene symbol Protein symbol 
Human LGR LGR 
Xenopus lgr Lgr 
Mouse Lgr Lgr 
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